{
 "cells": [
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:46:28.546687Z",
     "start_time": "2025-02-17T09:40:12.860054Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import pdfplumber\n",
    "import pytesseract\n",
    "from pdf2image import convert_from_path\n",
    "import pandas as pd\n",
    "import re\n",
    "from pdfminer.high_level import extract_text\n",
    "from pdfminer.layout import LAParams\n",
    "from bs4 import BeautifulSoup\n",
    "import PyPDF2\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from transformers import pipeline\n",
    "\n",
    "def pdf_to_html(pdf_path, html_path):\n",
    "    text = extract_text(pdf_path, laparams=LAParams())\n",
    "    html_content = f\"<html><body><pre>{text}</pre></body></html>\"\n",
    "    with open(html_path, \"w\", encoding=\"utf-8\") as f:\n",
    "        f.write(html_content)\n",
    "\n",
    "def extract_text_from_pdf(pdf_path):\n",
    "    extracted_text = \"\"\n",
    "    try:  \n",
    "        with pdfplumber.open(pdf_path) as pdf:\n",
    "            for page in pdf.pages:\n",
    "                text = page.extract_text()\n",
    "                if text:\n",
    "                    extracted_text += text + \"\\n\"\n",
    "                else:\n",
    "                    try: \n",
    "                        images = convert_from_path(pdf_path, first_page=page.page_number, last_page=page.page_number)\n",
    "                        for img in images:\n",
    "                            extracted_text += pytesseract.image_to_string(img) + \"\\n\"\n",
    "                    except Exception as e:\n",
    "                        print(f\"Error converting image on page {page.page_number}: {e}\")\n",
    "\n",
    "                        extracted_text += \"Error extracting image from this page.\\n\"\n",
    "    except Exception as e:\n",
    "        print(f\"Error opening or processing PDF: {e}\")\n",
    "        return None \n",
    "\n",
    "    return extracted_text\n",
    "\n",
    "def parse_financial_data(text):\n",
    "    revenue = re.findall(r\"Revenues\\s*[\\$]\\s*([\\d,]+)\", text)\n",
    "    operating_income = re.findall(r\"Operating income\\s*[\\$]\\s*([\\d,]+)\", text)\n",
    "    net_income = re.findall(r\"Net income\\s*[\\$]\\s*([\\d,]+)\", text)\n",
    "    \n",
    "    financial_data = {\n",
    "        \"revenue\": revenue,\n",
    "        \"operating_income\": operating_income,\n",
    "        \"net_income\": net_income\n",
    "    }\n",
    "    return financial_data\n",
    "\n",
    "def summarize_text(text):\n",
    "    try:\n",
    "        summarizer = pipeline(\"summarization\", model=\"facebook/bart-large-cnn\")\n",
    "        max_chunk_size = 1000\n",
    "        text_chunks = [text[i:i + max_chunk_size] for i in range(0, len(text), max_chunk_size)]\n",
    "        \n",
    "        summary = \"\"\n",
    "        for chunk in text_chunks:\n",
    "            chunk_summary = summarizer(chunk, max_length=200, min_length=50, do_sample=False)\n",
    "            if chunk_summary and isinstance(chunk_summary, list) and \"summary_text\" in chunk_summary[0]:\n",
    "                summary += chunk_summary[0][\"summary_text\"] + \" \"\n",
    "            else:\n",
    "                print(\"Warning: Summarization did not return any results for a chunk.\")\n",
    "                \n",
    "        if summary.strip() == \"\":\n",
    "            return \"No summary available.\"\n",
    "        \n",
    "        return summary.strip()\n",
    "    except Exception as e:\n",
    "        print(f\"Error during summarization: {e}\")\n",
    "        return \"Summarization failed.\"\n",
    "\n",
    "def plot_financial_trends(financial_data):\n",
    "    try:\n",
    "        if financial_data and financial_data[\"revenue\"] and financial_data[\"operating_income\"]: #check if it exists and has data\n",
    "            revenue_data = [int(value.replace(\",\", \"\")) for value in financial_data[\"revenue\"] if value]\n",
    "            operating_income_data = [int(value.replace(\",\", \"\")) for value in financial_data[\"operating_income\"] if value]\n",
    "            \n",
    "            min_length = min(len(revenue_data), len(operating_income_data))\n",
    "            revenue_data = revenue_data[:min_length]\n",
    "            operating_income_data = operating_income_data[:min_length]\n",
    "            \n",
    "            if revenue_data and operating_income_data: #check if the data lists are not empty\n",
    "                plt.figure(figsize=(10, 6))\n",
    "                plt.plot(revenue_data, marker='o', label=\"Revenue\")\n",
    "                plt.plot(operating_income_data, marker='s', label=\"Operating Income\")\n",
    "                plt.legend()\n",
    "                plt.title('Financial Trends (Revenue vs Operating Income)')\n",
    "                plt.xlabel('Data Points (e.g., Quarters)')\n",
    "                plt.ylabel('Amount ($)') #Removed millions from y-axis label\n",
    "                plt.show()\n",
    "            else:\n",
    "                print(\"Insufficient data for plotting financial trends.\")\n",
    "        else:\n",
    "            print(\"No revenue or operating income data found to plot.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error while plotting financial trends: {e}\")\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    pdf_path = r\"C:\\Users\\Aaarat\\Downloads\\FINAL-PR_HCA-Reports-4Q-2024-Results.pdf\"\n",
    "    pdf_text = extract_text_from_pdf(pdf_path)\n",
    "\n",
    "    if pdf_text:\n",
    "        financial_data = parse_financial_data(pdf_text)\n",
    "        print(\"Financial Data Extracted:\", financial_data)\n",
    "        summary = summarize_text(pdf_text)\n",
    "        print(\"Document Summary:\", summary)\n",
    "        plot_financial_trends(financial_data)\n",
    "    else:\n",
    "        print(\"No text extracted from PDF; please check the file and path.\")"
   ],
   "id": "913bf1b5476c7c6e",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Financial Data Extracted: {'revenue': ['72', '18,285', '70,603', '18,285', '72,800'], 'operating_income': [], 'net_income': ['6,657']}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cpu\n",
      "Your max_length is set to 200, but your input_length is only 190. Since this is a summarization task, where outputs shorter than the input are typically wanted, you might consider decreasing max_length manually, e.g. summarizer('...', max_length=95)\n",
      "Your max_length is set to 200, but your input_length is only 196. Since this is a summarization task, where outputs shorter than the input are typically wanted, you might consider decreasing max_length manually, e.g. summarizer('...', max_length=98)\n",
      "Your max_length is set to 200, but your input_length is only 197. Since this is a summarization task, where outputs shorter than the input are typically wanted, you might consider decreasing max_length manually, e.g. summarizer('...', max_length=98)\n",
      "Your max_length is set to 200, but your input_length is only 194. Since this is a summarization task, where outputs shorter than the input are typically wanted, you might consider decreasing max_length manually, e.g. summarizer('...', max_length=97)\n",
      "Your max_length is set to 200, but your input_length is only 131. Since this is a summarization task, where outputs shorter than the input are typically wanted, you might consider decreasing max_length manually, e.g. summarizer('...', max_length=65)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Document Summary: HCA announces financial and operating results for the fourth quarter ended December 31, 2024. Revenues totaled $18.285 billion. Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share. Same facility admissions increased 3.0 percent. Revenues in the fourth quarter of 2024 totaled $18.285 billion, compared to $17.303 billion in 2023. Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share. Results include losses on sales of facilities of $195 million. For the fourth quarter of 2024, Adjusted EBITDA totaled $3.712 billion. Same facility admissions increased 3.0 percent and same facility equivalent admissionsincreased 3.1 percent. Same hospital emergency room visits increased 2.4 percent. Revenues for the year ended December 31, 2024 totaled $70.603 billion. Net income attributable to HCA Healthcare, Inc. was $5.760 billion, or $22.00 per diluted share. For 2024, Adjusted EBITDA totaled $13.882 billion, compared to $12.726 billion in 2023. During the fourth quarter of 2024, the Company repurchased 4.739 million shares of its commonstock at a cost of $1.700 billion. The Company had $764 million remaining under its repurchase authorization as of December 31, 2024. The dividend will be paid on March 31, 2025 to stockholders of record at the close of business on March 17, 2025. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Future dividends are expected to be funded by cash balances and future cash flows from operations. For the year ended December 31, 2024, the Company incurred additional expenses and experienced loss of revenues estimated at $250 million, or $0.73 per diluted share. All facilities impacted by Hurricanes Helene and Milton have resumed normal operations. The Company issued the following estimated guidance for 2025. Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 to $6.2 billion. The Company’s guidance is based on current plans and expectations and is subject to anumber of assumptions. A table reconciling forecasted net income to forecasted Adjusted EBITDA is included in this release. HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The Company's 2025 annual stockholders' meeting will be held virtually on April 24, 2025. This press release contains forward-looking statements within the meaning of the federal                securities laws, which involve risks and uncertainties. Forward- looking statements include the                Company’s financial guidance for the year ending December 31, 2025, as well as other statements that do not relate solely to historical or current facts. Changes in revenues due to declining patient volumes, changes in payer mix. Potential increased expenses related to labor, supply chain or other expenditures. Potential workforce disruptions; supply shortages and geopolitical disruptions. Impact of potential federal shutdowns, the ability to refinance such indebtedness on acceptable terms. The study looks at the effects of sequestration spending reductions required under the Budget Control Act of 2011. It also looks at possible changes in Medicare, Medicaid and other state programs. The study also examines the size of the uninsured or underins, and the amount and risk of collectability of unins. Health care costs, capacity constraints, wage increases, competitive nature of the health care business, changes in service mix, revenue mix and surgical volumes, among other factors. The outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, among others. The company is concerned about pandemics, epidemics and outbreaks of infectious diseases or other public health crises, future divestitures which may result in charges and possible impairments of long-lived assets, changes in businessstrategy or development plans, delays in receiving payments for services provided, and the impact of known and unknown government investigations, litigation and other claims. Many of the factors that will determine our future results are beyond our ability to control or predict. The impact of recent decisions of the U.S. Supreme Court regarding the actions of federal agencies is also uncertain. The results of our efforts to use technology and resilience initiatives, including artificial intelligence and machinelearning, to drive efficiencies, better outcomes and an enhanced patient experience are not certain. The company's annual report on Form 10-K for the year ended December 31, 2023 and our other filings with the Securities and Exchange Commission. HCA Healthcare, Inc. erent in the forward-looking statements contained herein, and readers should not place undue reliance on such statements. All references to “Company,” “HCA” and ‘affiliates’ as used throughout this release refer to HCA Healthcare. HCA Healthcare, Inc. and its affiliates have a net loss of $1.6 billion for the years ended December 31, 2024 and 2023. The company's net income for the year was $1,429 million. Its diluted earnings per share was $ 5.93. Income before income taxes 8,523 12.1 7,706 11.9. Provision for income taxes 1,866 2.7 1,615 2.5. Interest expense 2,061 2.9 1,938 3.0. Losses (gains) on sales of facilities (14 ) — 5 —62,080 87.9 57,262 88.1. Net income attributable to HCA Healthcare, Inc. $ 5,798 $5,307 7.7. $ 59,513 $ 59,459 $ 56,211$ 29,414 29,047 27,715 $ 4,276 4,235 3,871 2,424 15,177 14,900 12,655 $ 38,333 38,283 37,169 1,903 1,867 2,041 1,982. HCA Healthcare, Inc. 060 $ 59,513 $ 59.459 $ 56,211 $ 56.211. The Company's net income for the year ended December 31, 2024 and 2023 was $ 6,657. The company's net cash provided by operating activities was 10,514 $ 9,431. HCA Healthcare, Inc. ange in investments (115 ) (112 ) Other (5 ) (19 )                Net cash used in investing activities (4,933 ) (5,317 )                Cash flows from financing activities:Issuances of long-term debt 7,495 3,224                Net change in revolving credit facilities (1,880 ) (1,.020 )                Repayment of long -term debt (2,410 ) (909 )                Distributions to noncontrolling interests (711 ) (640 )                 Reported: Admissions 559,170 544,554 2,236,595 2,130,728. Revenues as a Percentage of Patient Revenue 37.9 % 3.3 %Equivalent Patient Days 4,850,820 4,786,197 19,314,608 18,639,194. Inpatient Surgery Cases 135,643 132,417 540,704 528,845. Average Length of Stay (days) 4.814 4.911 4.920 4.941 4,920.Occupancy** 71.7 % 72.5% 72.7%. 72.3% 72,7% 72,.7% 71,7%. HCA Healthcare, Inc. and its subsidiaries reported net income of $1,438 for the quarter ended December 31, 2018. The company's adjusted net income for the fourth quarter was $5.63 per share. HCA's adjusted EBITDA was $12.7 million for the same period. Non-GAAP financial measures are adjusted to exclude losses (gains) on sales of facilities and losses on the retirement of debt. We believe net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, asadjusted, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations. HCA Healthcare, Inc. provides an overview of the company's financial results. The company also provides an analysis of the performance of its health care facilities and their management teams. It is reasonable to expect that adjustments, including losses (gains) on sales of facilities and losses on retirement of debt, will occur in future periods. Net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, asadjusted, and Adjusted EBITDA are not measures of financial performance under GAAP. They are not measurements determined in accordance with GAAP and are susceptible to varying calculations. They should not be considered as alternatives to net                income attributable to HCA healthcare, Inc. as a measure of operating performance. The Company's forecasted guidance is based on current plans and expectations. The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-term assets. Adjusted EBITDA is an important measure that supplements discussions and analysis of our results of operations. HCA does not believe that it can forecast these items with sufficient accuracy. We believe it is useful to investors to provide disclosures of ourresults of operations on the same basis used by management. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income attributable to HCA Healthcare, Inc. as a measure. It may not be comparable to other similarly titled measures presented by other companies.\n",
      "No revenue or operating income data found to plot.\n"
     ]
    }
   ],
   "execution_count": 4
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:49:38.360573Z",
     "start_time": "2025-02-17T09:49:29.729315Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import pdfplumber\n",
    "import pytesseract\n",
    "from pdf2image import convert_from_path\n",
    "import pandas as pd\n",
    "import re\n",
    "from pdfminer.high_level import extract_text\n",
    "from pdfminer.layout import LAParams\n",
    "from bs4 import BeautifulSoup\n",
    "\n",
    "def pdf_to_html(pdf_path, html_path):\n",
    "    text = extract_text(pdf_path, laparams=LAParams())\n",
    "    html_content = f\"<html><body><pre>{text}</pre></body></html>\"\n",
    "    with open(html_path, \"w\", encoding=\"utf-8\") as f:\n",
    "        f.write(html_content)\n",
    "\n",
    "def extract_text_from_pdf(pdf_path):\n",
    "    extracted_text = \"\"\n",
    "    with pdfplumber.open(pdf_path) as pdf:\n",
    "        for page in pdf.pages:\n",
    "            text = page.extract_text()\n",
    "            if text:\n",
    "                extracted_text += text + \"\\n\"\n",
    "            else:\n",
    "                images = convert_from_path(pdf_path, first_page=page.page_number, last_page=page.page_number)\n",
    "                for img in images:\n",
    "                    extracted_text += pytesseract.image_to_string(img) + \"\\n\"\n",
    "    return extracted_text\n",
    "\n",
    "def extract_all_data(text):\n",
    "    return text\n",
    "\n",
    "pdf_path = r\"C:\\Users\\Aaarat\\Downloads\\FINAL-PR_HCA-Reports-4Q-2024-Results.pdf\"\n",
    "html_path = \"output.html\"\n",
    "pdf_to_html(pdf_path, html_path)\n",
    "\n",
    "text = extract_text_from_pdf(pdf_path)\n",
    "with open(\"extracted_text.txt\", \"w\", encoding=\"utf-8\") as f:\n",
    "    f.write(text)\n",
    "\n",
    "print(\"Extracted Text from PDF:\")\n",
    "print(text)\n"
   ],
   "id": "b3a6033dea794f4f",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracted Text from PDF:\n",
      "FOR IMMEDIATE RELEASE\n",
      "INVESTOR CONTACT: MEDIA CONTACT:\n",
      "Frank Morgan Harlow Sumerford\n",
      "615-344-2688 615-344-1851\n",
      "HCA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS\n",
      "AND PROVIDES 2025 GUIDANCE\n",
      "Nashville, Tenn., January 24, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced\n",
      "financial and operating results for the fourth quarter ended December 31, 2024.\n",
      "Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless\n",
      "otherwise noted):\n",
      " Revenues totaled $18.285 billion\n",
      " Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per\n",
      "diluted share (which includes an estimated $0.60 per diluted share unfavorable impact\n",
      "from Hurricanes Helene and Milton)\n",
      " Adjusted EBITDA totaled $3.712 billion\n",
      " Cash flows from operating activities totaled $2.559 billion\n",
      " Same facility admissions increased 3.0 percent and same facility equivalent admissions\n",
      "increased 3.1 percent\n",
      "\"We finished 2024 with strong business fundamentals that were consistent with previous\n",
      "quarters,\" said Sam Hazen, Chief Executive Officer of HCA Healthcare. \"The first half of the\n",
      "current decade, which ended in 2024, proved to be another period of long-term growth for the\n",
      "company and resulted in operational improvements across key performance indicators and\n",
      "greater value for our patients, employees and shareholders. These accomplishments are a\n",
      "testament to the incredible work of our teams, and position us well for the future.\"\n",
      "Revenues in the fourth quarter of 2024 totaled $18.285 billion, compared to $17.303 billion in\n",
      "the fourth quarter of 2023. Net income attributable to HCA Healthcare, Inc. totaled $1.438\n",
      "billion, or $5.63 per diluted share, compared to $1.607 billion, or $5.93 per diluted share, in the\n",
      "fourth quarter of 2023. Results for the fourth quarter of 2024 include losses on sales of facilities\n",
      "of $195 million, or $0.59 per diluted share, primarily related to the pending sale of a hospital\n",
      "facility in California. Results for the fourth quarter of 2023 include gains on sales of facilities of\n",
      "$7 million, or $0.03 per diluted share.\n",
      "For the fourth quarter of 2024, Adjusted EBITDA totaled $3.712 billion, compared to $3.618\n",
      "billion in the fourth quarter of 2023. Adjusted EBITDA is a non-GAAP financial measure. A table\n",
      "providing supplemental information on Adjusted EBITDA and reconciling net income attributable\n",
      "to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release.\n",
      "1\n",
      "Same facility admissions increased 3.0 percent and same facility equivalent admissions\n",
      "increased 3.1 percent in the fourth quarter of 2024, compared to the prior year period. Same\n",
      "facility emergency room visits increased 2.4 percent in the fourth quarter of 2024, compared to\n",
      "the prior year period. Same facility inpatient surgeries increased 2.8 percent, and same facility\n",
      "outpatient surgeries declined 1.3 percent in the fourth quarter of 2024, compared to the same\n",
      "period of 2023. Same facility revenue per equivalent admission increased 2.9 percent in the\n",
      "fourth quarter of 2024, compared to the fourth quarter of 2023.\n",
      "Year Ended December 31, 2024\n",
      "Revenues for the year ended December 31, 2024 totaled $70.603 billion, compared to $64.968\n",
      "billion for the year ended December 31, 2023. Net income attributable to HCA Healthcare, Inc.\n",
      "was $5.760 billion, or $22.00 per diluted share, compared to $5.242 billion, or $18.97 per diluted\n",
      "share, for the year ended December 31, 2023. Results for the year ended December 31, 2024\n",
      "include gains on sales of facilities of $14 million, or $0.04 per diluted share. Results for the year\n",
      "ended December 31, 2023 included losses on sales of facilities of $5 million, or $0.04 per\n",
      "diluted share.\n",
      "For 2024, Adjusted EBITDA totaled $13.882 billion, compared to $12.726 billion in 2023.\n",
      "Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information\n",
      "on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to\n",
      "Adjusted EBITDA is included in this release.\n",
      "Balance Sheet and Cash Flows from Operations\n",
      "As of December 31, 2024, HCA Healthcare, Inc.’s balance sheet reflected cash and cash\n",
      "equivalents of $1.933 billion, total debt of $43.031 billion, and total assets of $59.513 billion.\n",
      "During the fourth quarter of 2024, capital expenditures totaled $1.285 billion, excluding\n",
      "acquisitions. Cash flows provided by operating activities in the fourth quarter of 2024 totaled\n",
      "$2.559 billion, compared to $2.674 billion in the fourth quarter of 2023.\n",
      "During the fourth quarter of 2024, the Company repurchased 4.739 million shares of its common\n",
      "stock at a cost of $1.700 billion. The Company had $764 million remaining under its repurchase\n",
      "authorization as of December 31, 2024. As of December 31, 2024, the Company had $7.986\n",
      "billion of availability under its credit facilities.\n",
      "Share Repurchase Program\n",
      "The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase\n",
      "program for up to $10 billion of the Company’s outstanding common stock. Repurchases will be\n",
      "made in accordance with applicable securities laws and may be made at management’s\n",
      "discretion from time to time in the open market, through privately negotiated transactions, or\n",
      "otherwise. The repurchase program has no time limit and may be suspended for periods or\n",
      "discontinued at any time.\n",
      "Dividend\n",
      "HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.72\n",
      "per share on the Company’s common stock. The dividend will be paid on March 31, 2025 to\n",
      "stockholders of record at the close of business on March 17, 2025.\n",
      "2\n",
      "The declaration and payment of any future dividend will be subject to the discretion of the Board\n",
      "of Directors and will depend on a variety of factors, including the Company’s financial condition,\n",
      "results of operations, and contractual restrictions. Future dividends are expected to be funded\n",
      "by cash balances and future cash flows from operations.\n",
      "Impact of Hurricanes\n",
      "During the fourth quarter of 2024, the Company incurred additional expenses and experienced\n",
      "loss of revenues estimated at $200 million, or $0.60 per diluted share, associated with Hurricane\n",
      "Helene's impact on its North Carolina facilities, as well as from Hurricane Milton, which impacted\n",
      "certain facilities in Florida.\n",
      "For the year ended December 31, 2024, the Company incurred additional expenses and\n",
      "experienced loss of revenues estimated at $250 million, or $0.73 per diluted share, associated\n",
      "with the impact of Hurricanes Helene and Milton on the Company's North Carolina facilities and\n",
      "certain facilities in Florida.\n",
      "These estimates do not include any insurance recoveries the Company may receive. All\n",
      "facilities impacted by Hurricanes Helene and Milton have resumed normal operations.\n",
      "2025 Guidance\n",
      "Today, the Company issued the following estimated guidance for 2025:\n",
      "2025 Guidance Range\n",
      "Revenues $72.80 to $75.80 billion\n",
      "Net Income Attributable to HCA Healthcare, Inc. $5.85 to $6.29 billion\n",
      "Adjusted EBITDA $14.30 to $15.10 billion\n",
      "EPS (diluted) $24.05 to $25.85 per\n",
      "diluted share\n",
      "Capital expenditures for 2025, excluding acquisitions, are estimated to be approximately $5.0 to\n",
      "$5.2 billion.\n",
      "The Company’s guidance contains a number of assumptions, including, among others, the\n",
      "Company’s current expectations regarding volume growth coupled with an anticipated mostly\n",
      "stable operating environment, payer mix, and the ongoing impacts of the two major hurricanes,\n",
      "the impact of current and future health care public policy developments, as well as general\n",
      "economic conditions, including inflation, and excludes the impact of items such as, but not\n",
      "limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs\n",
      "and impairment of long-lived assets.\n",
      "Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income\n",
      "attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.\n",
      "The Company’s guidance is based on current plans and expectations and are subject to a\n",
      "number of known and unknown uncertainties and risks, including those set forth below in the\n",
      "Company’s “Forward-Looking Statements.”\n",
      "3\n",
      "Annual Stockholders' Meeting\n",
      "The Company's 2025 annual stockholders' meeting will be held virtually on April 24, 2025 at\n",
      "2:00 p.m. Central Time for stockholders of record as of February 24, 2025.\n",
      "Earnings Conference Call\n",
      "HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Time today. All\n",
      "interested investors are invited to access a live audio broadcast of the call via webcast. The\n",
      "broadcast also will be available on a replay basis beginning this afternoon. The webcast can be\n",
      "accessed through the Company’s Investor Relations web page at\n",
      "https://investor.hcahealthcare.com/events-and-presentations/default.aspx.\n",
      "About the Company\n",
      "As of December 31, 2024, HCA operated 190 hospitals and approximately 2,400 ambulatory\n",
      "sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and\n",
      "physician clinics, in 20 states and the United Kingdom.\n",
      "Forward-Looking Statements\n",
      "This press release contains forward-looking statements within the meaning of the federal\n",
      "securities laws, which involve risks and uncertainties. Forward-looking statements include the\n",
      "Company’s financial guidance for the year ending December 31, 2025, as well as other\n",
      "statements that do not relate solely to historical or current facts. Forward-looking statements can\n",
      "be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,”\n",
      "“anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our\n",
      "current plans and expectations and are subject to a number of known and unknown\n",
      "uncertainties and risks, many of which are beyond our control, which could significantly affect\n",
      "current plans and expectations and our future financial position and results of operations. These\n",
      "factors include, but are not limited to, (1) changes in or related to general economic conditions\n",
      "nationally and regionally in our markets, including inflation and economic and business\n",
      "conditions (and the impact thereof on the economy, financial markets and banking industry);\n",
      "changes in revenues due to declining patient volumes; changes in payer mix (including\n",
      "increases in uninsured and underinsured patients); potential increased expenses related to\n",
      "labor, supply chain or other expenditures; workforce disruptions; supply shortages and\n",
      "disruptions (including as a result of geopolitical disruptions); and the impact of potential federal\n",
      "government shutdowns, (2) the impact of our significant indebtedness and the ability to\n",
      "refinance such indebtedness on acceptable terms, (3) the impact of current and future health\n",
      "care public policy developments and possible changes to other federal, state or local laws and\n",
      "regulations affecting the health care industry, including, but not limited to, the expiration of\n",
      "enhanced premium tax credits for individuals eligible to purchase insurance coverage through\n",
      "federal and state-based health insurance marketplaces, (4) the effects related to the\n",
      "implementation of sequestration spending reductions required under the Budget Control Act of\n",
      "2011, related legislation extending these reductions, and the potential for future deficit reduction\n",
      "legislation that may alter these spending reductions, which include cuts to Medicare payments,\n",
      "or create additional spending reductions, (5) increases in the amount and risk of collectability of\n",
      "uninsured accounts and deductibles and copayment amounts for insured accounts, (6) the\n",
      "ability to achieve operating and financial targets, attain expected levels of patient volumes and\n",
      "revenues, and control the costs of providing services, (7) possible changes in Medicare,\n",
      "Medicaid and other state programs, including Medicaid supplemental payment programs,\n",
      "Medicaid waiver programs or state directed payments, that may impact reimbursements to\n",
      "4\n",
      "health care providers and insurers and the size of the uninsured or underinsured population, (8)\n",
      "personnel-related capacity constraints, increases in wages and the ability to attract, utilize and\n",
      "retain qualified management and other personnel, including affiliated physicians, nurses and\n",
      "medical and technical support personnel, (9) the highly competitive nature of the health care\n",
      "business, (10) changes in service mix, revenue mix and surgical volumes, including potential\n",
      "declines in the population covered under third-party payer agreements, the ability to enter into\n",
      "and renew third-party payer provider agreements on acceptable terms and the impact of\n",
      "consumer-driven health plans and physician utilization trends and practices, (11) the efforts of\n",
      "health insurers, health care providers, large employer groups and others to contain health care\n",
      "costs, (12) the outcome of our continuing efforts to monitor, maintain and comply with\n",
      "appropriate laws, regulations, policies and procedures, (13) the availability and terms of capital\n",
      "to fund the expansion of our business and improvements to our existing facilities, (14) changes\n",
      "in accounting practices, (15) the emergence of and effects related to pandemics, epidemics and\n",
      "outbreaks of infectious diseases or other public health crises, (16) future divestitures which may\n",
      "result in charges and possible impairments of long-lived assets, (17) changes in business\n",
      "strategy or development plans, (18) delays in receiving payments for services provided, (19) the\n",
      "outcome of pending and any future tax audits, disputes and litigation associated with our tax\n",
      "positions, (20) the impact of known and unknown government investigations, litigation and other\n",
      "claims that may be made against us, (21) the impact of actual and potential cybersecurity\n",
      "incidents or security breaches involving us or our vendors and other third parties, (22) our\n",
      "ongoing ability to demonstrate meaningful use of certified electronic health record technology\n",
      "and the impact of interoperability requirements, (23) the impact of natural disasters, such as\n",
      "hurricanes and floods, including Hurricanes Milton and Helene, physical risks from climate\n",
      "change or similar events beyond our control on our assets and activities and the communities\n",
      "we serve, (24) changes in U.S. federal, state, or foreign tax laws including interpretive guidance\n",
      "that may be issued by taxing authorities or other standard setting bodies, (25) the results of our\n",
      "efforts to use technology and resilience initiatives, including artificial intelligence and machine\n",
      "learning, to drive efficiencies, better outcomes and an enhanced patient experience, (26) the\n",
      "impact of recent decisions of the U.S. Supreme Court regarding the actions of federal agencies,\n",
      "and (27) other risk factors described in our annual report on Form 10-K for the year ended\n",
      "December 31, 2023 and our other filings with the Securities and Exchange Commission. Many\n",
      "of the factors that will determine our future results are beyond our ability to control or predict. In\n",
      "light of the significant uncertainties inherent in the forward-looking statements contained herein,\n",
      "readers should not place undue reliance on forward-looking statements, which reflect\n",
      "management’s views only as of the date hereof. We undertake no obligation to revise or update\n",
      "any forward-looking statements, or to make any other forward-looking statements, whether as a\n",
      "result of new information, future events or otherwise. All references to “Company,” “HCA” and\n",
      "“HCA Healthcare” as used throughout this release refer to HCA Healthcare, Inc. and its\n",
      "affiliates.\n",
      "5\n",
      "HCA Healthcare, Inc.\n",
      "Condensed Consolidated Comprehensive Income Statements\n",
      "Fourth Quarter\n",
      "Unaudited\n",
      "(Dollars in millions, except per share amounts)\n",
      "2024 2023\n",
      "Amount Ratio Amount Ratio\n",
      "Revenues $ 18,285 100.0 % $ 17,303 100.0 %\n",
      "Salaries and benefits 7,917 43.3 7,570 43.7\n",
      "Supplies 2,793 15.3 2,584 14.9\n",
      "Other operating expenses 3,873 21.2 3,559 20.7\n",
      "Equity in earnings of affiliates (10 ) (0.1 ) (28 ) (0.2 )\n",
      "Depreciation and amortization 856 4.6 789 4.5\n",
      "Interest expense 528 2.9 491 2.8\n",
      "Losses (gains) on sales of facilities 195 1.1 (7 ) —\n",
      "16,152 88.3 14,958 86.4\n",
      "Income before income taxes 2,133 11.7 2,345 13.6\n",
      "Provision for income taxes 447 2.5 484 2.8\n",
      "Net income 1,686 9.2 1,861 10.8\n",
      "Net income attributable to noncontrolling interests 248 1.3 254 1.5\n",
      "Net income attributable to HCA Healthcare, Inc. $ 1,438 7.9 $ 1,607 9.3\n",
      "Diluted earnings per share $ 5.63 $ 5.93\n",
      "Shares used in computing diluted earnings per share (millions) 255.310 271.186\n",
      "Comprehensive income attributable to HCA Healthcare, Inc. $ 1,429 $ 1,673\n",
      "6\n",
      "HCA Healthcare, Inc.\n",
      "Condensed Consolidated Comprehensive Income Statements\n",
      "For the Years Ended December 31, 2024 and 2023\n",
      "Unaudited\n",
      "(Dollars in millions, except per share amounts)\n",
      "2024 2023\n",
      "Amount Ratio Amount Ratio\n",
      "Revenues $ 70,603 100.0 % $ 64,968 100.0 %\n",
      "Salaries and benefits 31,170 44.1 29,487 45.4\n",
      "Supplies 10,755 15.2 9,902 15.2\n",
      "Other operating expenses 14,819 21.0 12,875 19.8\n",
      "Equity in earnings of affiliates (23 ) — (22 ) —\n",
      "Depreciation and amortization 3,312 4.7 3,077 4.7\n",
      "Interest expense 2,061 2.9 1,938 3.0\n",
      "Losses (gains) on sales of facilities (14 ) — 5 —\n",
      "62,080 87.9 57,262 88.1\n",
      "Income before income taxes 8,523 12.1 7,706 11.9\n",
      "Provision for income taxes 1,866 2.7 1,615 2.5\n",
      "Net income 6,657 9.4 6,091 9.4\n",
      "Net income attributable to noncontrolling interests 897 1.2 849 1.3\n",
      "Net income attributable to HCA Healthcare, Inc. $ 5,760 8.2 $ 5,242 8.1\n",
      "Diluted earnings per share $ 22.00 $ 18.97\n",
      "Shares used in computing diluted earnings per share (millions) 261.806 276.412\n",
      "Comprehensive income attributable to HCA Healthcare, Inc. $ 5,798 $ 5,307\n",
      "7\n",
      "HCA Healthcare, Inc.\n",
      "Condensed Consolidated Balance Sheets\n",
      "Unaudited\n",
      "(Dollars in millions)\n",
      "December 31, September 30, December 31,\n",
      "2024 2024 2023\n",
      "ASSETS\n",
      "Current assets:\n",
      "Cash and cash equivalents $ 1,933 $ 2,888 $ 935\n",
      "Accounts receivable 10,751 9,915 9,958\n",
      "Inventories 1,738 1,776 2,021\n",
      "Other 1,992 2,083 2,013\n",
      "16,414 16,662 14,927\n",
      "Property and equipment, at cost 62,514 61,750 58,548\n",
      "Accumulated depreciation (33,100 ) (32,703 ) (30,833 )\n",
      "29,414 29,047 27,715\n",
      "Investments of insurance subsidiaries 569 553 477\n",
      "Investments in and advances to affiliates 662 705 756\n",
      "Goodwill and other intangible assets 10,093 9,982 9,945\n",
      "Right-of-use operating lease assets 2,131 2,201 2,207\n",
      "Other 230 309 184\n",
      "$ 59,513 $ 59,459 $ 56,211\n",
      "LIABILITIES AND STOCKHOLDERS' EQUITY\n",
      "Current liabilities:\n",
      "Accounts payable $ 4,276 $ 4,235 $ 4,233\n",
      "Accrued salaries 2,304 2,164 2,127\n",
      "Other accrued expenses 3,899 3,819 3,871\n",
      "Long-term debt due within one year 4,698 4,682 2,424\n",
      "15,177 14,900 12,655\n",
      "Long-term debt, less debt issuance costs and discounts\n",
      "of $369, $378 and $333 38,333 38,283 37,169\n",
      "Professional liability risks 1,544 1,584 1,557\n",
      "Right-of-use operating lease obligations 1,863 1,924 1,903\n",
      "Income taxes and other liabilities 2,041 1,982 1,867\n",
      "Stockholders' equity:\n",
      "Stockholders' deficit attributable to HCA Healthcare, Inc. (2,499 ) (2,182 ) (1,774 )\n",
      "Noncontrolling interests 3,054 2,968 2,834\n",
      "555 786 1,060\n",
      "$ 59,513 $ 59,459 $ 56,211\n",
      "8\n",
      "HCA Healthcare, Inc.\n",
      "Condensed Consolidated Statements of Cash Flows\n",
      "For the Years Ended December 31, 2024 and 2023\n",
      "Unaudited\n",
      "(Dollars in millions)\n",
      "2024 2023\n",
      "Cash flows from operating activities:\n",
      "Net income $ 6,657 $ 6,091\n",
      "Adjustments to reconcile net income to net cash provided by operating activities:\n",
      "Increase (decrease) in cash from operating assets and liabilities:\n",
      "Accounts receivable (799 ) (935 )\n",
      "Inventories and other assets 334 (126 )\n",
      "Accounts payable and accrued expenses 359 604\n",
      "Depreciation and amortization 3,312 3,077\n",
      "Income taxes 22 229\n",
      "Losses (gains) on sales of facilities (14 ) 5\n",
      "Amortization of debt issuance costs and discounts 35 35\n",
      "Share-based compensation 360 262\n",
      "Other 248 189\n",
      "Net cash provided by operating activities 10,514 9,431\n",
      "Cash flows from investing activities:\n",
      "Purchase of property and equipment (4,875 ) (4,744 )\n",
      "Acquisition of hospitals and health care entities (266 ) (635 )\n",
      "Sales of hospitals and health care entities 328 193\n",
      "Change in investments (115 ) (112 )\n",
      "Other (5 ) (19 )\n",
      "Net cash used in investing activities (4,933 ) (5,317 )\n",
      "Cash flows from financing activities:\n",
      "Issuances of long-term debt 7,495 3,224\n",
      "Net change in revolving credit facilities (1,880 ) (1,020 )\n",
      "Repayment of long-term debt (2,410 ) (909 )\n",
      "Distributions to noncontrolling interests (711 ) (640 )\n",
      "Payment of debt issuance costs (67 ) (31 )\n",
      "Payment of dividends (690 ) (661 )\n",
      "Repurchase of common stock (6,042 ) (3,811 )\n",
      "Other (277 ) (246 )\n",
      "Net cash used in financing activities (4,582 ) (4,094 )\n",
      "Effect of exchange rate changes on cash and cash equivalents (1 ) 7\n",
      "Change in cash and cash equivalents 998 27\n",
      "Cash and cash equivalents at beginning of period 935 908\n",
      "Cash and cash equivalents at end of period $ 1,933 $ 935\n",
      "Interest payments $ 1,938 $ 1,892\n",
      "Income tax payments, net $ 1,844 $ 1,386\n",
      "9\n",
      "HCA Healthcare, Inc.\n",
      "Operating Statistics\n",
      "For the Years\n",
      "Fourth Quarter Ended December 31,\n",
      "2024 2023 2024 2023\n",
      "Operations:\n",
      "Number of Hospitals 190 186 190 186\n",
      "Number of Freestanding Outpatient\n",
      "Surgery Centers* 124 124 124 124\n",
      "Licensed Beds at End of Period 49,985 49,588 49,985 49,588\n",
      "Weighted Average Beds in Service 42,705 42,072 42,633 41,873\n",
      "Reported:\n",
      "Admissions 559,170 544,554 2,236,595 2,130,728\n",
      "% Change 2.7 % 5.0 %\n",
      "Equivalent Admissions 1,007,623 974,561 3,990,085 3,788,434\n",
      "% Change 3.4 % 5.3 %\n",
      "Revenue per Equivalent Admission $ 18,146 $ 17,755 $ 17,695 $ 17,149\n",
      "% Change 2.2 % 3.2 %\n",
      "Inpatient Revenue per Admission $ 19,737 $ 18,992 $ 19,050 $ 18,201\n",
      "% Change 3.9 % 4.7 %\n",
      "Patient Days 2,691,710 2,674,331 10,826,574 10,483,236\n",
      "% Change 0.6 % 3.3 %\n",
      "Equivalent Patient Days 4,850,820 4,786,197 19,314,608 18,639,194\n",
      "% Change 1.4 % 3.6 %\n",
      "Inpatient Surgery Cases 135,643 132,417 540,704 528,845\n",
      "% Change 2.4 % 2.2 %\n",
      "Outpatient Surgery Cases 263,832 270,286 1,024,998 1,044,415\n",
      "% Change -2.4 % -1.9 %\n",
      "Emergency Room Visits 2,498,429 2,452,395 9,789,265 9,342,783\n",
      "% Change 1.9 % 4.8 %\n",
      "Outpatient Revenues as a\n",
      "Percentage of Patient Revenues 37.9 % 38.4 % 37.8 % 38.3 %\n",
      "Average Length of Stay (days) 4.814 4.911 4.841 4.920\n",
      "Occupancy** 71.7 % 72.5 % 72.7 % 72.3 %\n",
      "Same Facility:\n",
      "Admissions 552,610 536,350 2,204,148 2,101,839\n",
      "% Change 3.0 % 4.9 %\n",
      "Equivalent Admissions 980,330 950,949 3,881,505 3,713,950\n",
      "% Change 3.1 % 4.5 %\n",
      "Revenue per Equivalent Admission $ 18,185 $ 17,674 $ 17,625 $ 17,071\n",
      "% Change 2.9 % 3.2 %\n",
      "Inpatient Revenue per Admission $ 19,835 $ 19,006 $ 19,085 $ 18,185\n",
      "% Change 4.4 % 4.9 %\n",
      "Inpatient Surgery Cases 134,482 130,779 534,330 523,074\n",
      "% Change 2.8 % 2.2 %\n",
      "Outpatient Surgery Cases 257,663 261,155 997,043 1,013,752\n",
      "% Change -1.3 % -1.6 %\n",
      "Emergency Room Visits 2,466,784 2,410,050 9,642,016 9,192,154\n",
      "% Change 2.4 % 4.9 %\n",
      "* Excludes freestanding endoscopy centers (26 centers at December 31, 2024 and 24 centers at December 31, 2023).\n",
      "** Reflects the rate of occupancy (patient days and observations) based on weighted average beds in service.\n",
      "10\n",
      "HCA Healthcare, Inc.\n",
      "Supplemental Non-GAAP Disclosures\n",
      "Operating Results Summary\n",
      "(Dollars in millions, except per share amounts)\n",
      "For the Years\n",
      "Fourth Quarter Ended December 31,\n",
      "2024 2023 2024 2023\n",
      "Revenues $ 18,285 $ 17,303 $ 70,603 $ 64,968\n",
      "Net income attributable to HCA Healthcare, Inc. $ 1,438 $ 1,607 $ 5,760 $ 5,242\n",
      "Losses (gains) on sales of facilities (net of tax) 149 (9 ) (11 ) 12\n",
      "Net income attributable to HCA Healthcare, Inc.,\n",
      "as adjusted (a) 1,587 1,598 5,749 5,254\n",
      "Depreciation and amortization 856 789 3,312 3,077\n",
      "Interest expense 528 491 2,061 1,938\n",
      "Provision for income taxes 493 486 1,863 1,608\n",
      "Net income attributable to noncontrolling interests 248 254 897 849\n",
      "Adjusted EBITDA (a) 3,712 $ 3,618 $ 13,882 $ 12,726\n",
      "Adjusted EBITDA margin (a) 20.3 % 20.9 % 19.7 % 19.6 %\n",
      "Diluted earnings per share:\n",
      "Net income attributable to HCA Healthcare, Inc. $ 5.63 $ 5.93 $ 22.00 $ 18.97\n",
      "Losses (gains) on sales of facilities 0.59 (0.03 ) (0.04 ) 0.04\n",
      "Net income attributable to HCA Healthcare, Inc.,\n",
      "as adjusted (a) $ 6.22 $ 5.90 $ 21.96 $ 19.01\n",
      "Shares used in computing diluted earnings per\n",
      "share (millions) 255.310 271.186 261.806 276.412\n",
      "(a) Net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted\n",
      "EBITDA should not be considered as measures of financial performance under generally accepted accounting principles\n",
      "(\"GAAP\"). These non-GAAP financial measures are adjusted to exclude losses (gains) on sales of facilities and losses on\n",
      "retirement of debt. We believe net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as\n",
      "adjusted, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of\n",
      "operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used\n",
      "by management. Management relies upon net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings\n",
      "per share, as adjusted, and Adjusted EBITDA as the primary measures to review and assess operating performance of its\n",
      "health care facilities and their management teams.\n",
      "Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc.,\n",
      "as adjusted, diluted earnings per share, as adjusted, and GAAP net income attributable to HCA Healthcare, Inc.) and\n",
      "operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin\n",
      "(Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results\n",
      "with the corresponding periods during the previous year and to compare our operating results with other companies in the\n",
      "health care industry. It is reasonable to expect that adjustments, including losses (gains) on sales of facilities and losses on\n",
      "retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do\n",
      "not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of\n",
      "operations and operations comparisons with other health care companies.\n",
      "Net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings per share, as adjusted, and Adjusted\n",
      "EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net\n",
      "income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing\n",
      "and financing activities as a measure of liquidity. Because net income attributable to HCA Healthcare, Inc., as adjusted,\n",
      "diluted earnings per share, as adjusted, and Adjusted EBITDA are not measurements determined in accordance with GAAP\n",
      "and are susceptible to varying calculations, net income attributable to HCA Healthcare, Inc., as adjusted, diluted earnings\n",
      "per share, as adjusted, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures\n",
      "presented by other companies.\n",
      "11\n",
      "HCA Healthcare, Inc.\n",
      "Supplemental Non-GAAP Disclosures\n",
      "2025 Operating Results Forecast\n",
      "(Dollars in millions, except per share amounts)\n",
      "For the Year Ending\n",
      "December 31, 2025\n",
      "Low High\n",
      "Revenues $ 72,800 $ 75,800\n",
      "Net income attributable to HCA Healthcare, Inc. (a) $ 5,850 $ 6,290\n",
      "Depreciation and amortization 3,495 3,565\n",
      "Interest expense 2,230 2,320\n",
      "Provision for income taxes 1,800 1,950\n",
      "Net income attributable to noncontrolling interests 925 975\n",
      "Adjusted EBITDA (a) (b) $ 14,300 $ 15,100\n",
      "Diluted earnings per share:\n",
      "Net income attributable to HCA Healthcare, Inc. $ 24.05 $ 25.85\n",
      "Shares used in computing diluted earnings per share (millions) 243.000 243.000\n",
      "The Company's forecasted guidance is based on current plans and expectations and is subject to a number\n",
      "of known and unknown uncertainties and risks.\n",
      "(a) The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales\n",
      "of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-lived\n",
      "assets because the Company does not believe that it can forecast these items with sufficient accuracy.\n",
      "(b) Adjusted EBITDA should not be considered a measure of financial performance under generally accepted\n",
      "accounting principles (\"GAAP\"). We believe Adjusted EBITDA is an important measure that supplements\n",
      "discussions and analysis of our results of operations. We believe it is useful to investors to provide\n",
      "disclosures of our results of operations on the same basis used by management. Management relies upon\n",
      "Adjusted EBITDA as a primary measure to review and assess operating performance of its health care\n",
      "facilities and their management teams.\n",
      "Management and investors review both the overall performance (including net income attributable to HCA\n",
      "Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our healthcare facilities. Adjusted EBITDA\n",
      "is utilized by management and investors to compare our current operating results with the corresponding\n",
      "periods during the previous year and to compare our operating results with other companies in the health\n",
      "care industry.\n",
      "Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an\n",
      "alternative to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash\n",
      "flows from operating, investing and financing activities as a measure of liquidity. Because Adjusted EBITDA is\n",
      "not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted\n",
      "EBITDA, as presented, may not be comparable to other similarly titled measures presented by other\n",
      "companies.\n",
      "12\n",
      "\n"
     ]
    }
   ],
   "execution_count": 8
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:46:30.834066Z",
     "start_time": "2025-02-17T09:46:28.602767Z"
    }
   },
   "cell_type": "code",
   "source": [
    "text = pdf_text\n",
    "import nltk\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.tokenize import word_tokenize, sent_tokenize\n",
    "\n",
    "nltk.download('punkt')\n",
    "nltk.download('stopwords')\n",
    "\n",
    "def preprocess_text(text):\n",
    "    sentences = sent_tokenize(text)\n",
    "    stop_words = set(stopwords.words('english'))\n",
    "    processed_sentences = []\n",
    "\n",
    "    for sentence in sentences:\n",
    "        words = word_tokenize(sentence)\n",
    "        filtered_words = [word for word in words if word.lower() not in stop_words]\n",
    "        processed_sentences.append(' '.join(filtered_words))\n",
    "    \n",
    "    return processed_sentences\n",
    "\n",
    "processed_sentences = preprocess_text(text)\n",
    "print(processed_sentences)\n"
   ],
   "id": "811e806bfe12a9bc",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\Aaarat\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\Aaarat\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['IMMEDIATE RELEASE INVESTOR CONTACT : MEDIA CONTACT : Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS PROVIDES 2025 GUIDANCE Nashville , Tenn. , January 24 , 2025 – HCA Healthcare , Inc. ( NYSE : HCA ) today announced financial operating results fourth quarter ended December 31 , 2024 .', \"Key fourth quarter metrics ( percentage changes compare 4Q 2024 4Q 2023 unless otherwise noted ) : \\uf0b7 Revenues totaled $ 18.285 billion \\uf0b7 Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share ( includes estimated $ 0.60 per diluted share unfavorable impact Hurricanes Helene Milton ) \\uf0b7 Adjusted EBITDA totaled $ 3.712 billion \\uf0b7 Cash flows operating activities totaled $ 2.559 billion \\uf0b7 facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent '' finished 2024 strong business fundamentals consistent previous quarters , '' said Sam Hazen , Chief Executive Officer HCA Healthcare .\", '`` first half current decade , ended 2024 , proved another period long-term growth company resulted operational improvements across key performance indicators greater value patients , employees shareholders .', \"accomplishments testament incredible work teams , position us well future . ''\", 'Revenues fourth quarter 2024 totaled $ 18.285 billion , compared $ 17.303 billion fourth quarter 2023 .', 'Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share , compared $ 1.607 billion , $ 5.93 per diluted share , fourth quarter 2023 .', 'Results fourth quarter 2024 include losses sales facilities $ 195 million , $ 0.59 per diluted share , primarily related pending sale hospital facility California .', 'Results fourth quarter 2023 include gains sales facilities $ 7 million , $ 0.03 per diluted share .', 'fourth quarter 2024 , Adjusted EBITDA totaled $ 3.712 billion , compared $ 3.618 billion fourth quarter 2023 .', 'Adjusted EBITDA non-GAAP financial measure .', 'table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .', '1 facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent fourth quarter 2024 , compared prior year period .', 'facility emergency room visits increased 2.4 percent fourth quarter 2024 , compared prior year period .', 'facility inpatient surgeries increased 2.8 percent , facility outpatient surgeries declined 1.3 percent fourth quarter 2024 , compared period 2023 .', 'facility revenue per equivalent admission increased 2.9 percent fourth quarter 2024 , compared fourth quarter 2023 .', 'Year Ended December 31 , 2024 Revenues year ended December 31 , 2024 totaled $ 70.603 billion , compared $ 64.968 billion year ended December 31 , 2023 .', 'Net income attributable HCA Healthcare , Inc. $ 5.760 billion , $ 22.00 per diluted share , compared $ 5.242 billion , $ 18.97 per diluted share , year ended December 31 , 2023 .', 'Results year ended December 31 , 2024 include gains sales facilities $ 14 million , $ 0.04 per diluted share .', 'Results year ended December 31 , 2023 included losses sales facilities $ 5 million , $ 0.04 per diluted share .', '2024 , Adjusted EBITDA totaled $ 13.882 billion , compared $ 12.726 billion 2023 .', 'Adjusted EBITDA non-GAAP financial measure .', 'table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .', 'Balance Sheet Cash Flows Operations December 31 , 2024 , HCA Healthcare , Inc. ’ balance sheet reflected cash cash equivalents $ 1.933 billion , total debt $ 43.031 billion , total assets $ 59.513 billion .', 'fourth quarter 2024 , capital expenditures totaled $ 1.285 billion , excluding acquisitions .', 'Cash flows provided operating activities fourth quarter 2024 totaled $ 2.559 billion , compared $ 2.674 billion fourth quarter 2023 .', 'fourth quarter 2024 , Company repurchased 4.739 million shares common stock cost $ 1.700 billion .', 'Company $ 764 million remaining repurchase authorization December 31 , 2024 .', 'December 31 , 2024 , Company $ 7.986 billion availability credit facilities .', 'Share Repurchase Program HCA Healthcare , Inc. Board Directors authorized additional share repurchase program $ 10 billion Company ’ outstanding common stock .', 'Repurchases made accordance applicable securities laws may made management ’ discretion time time open market , privately negotiated transactions , otherwise .', 'repurchase program time limit may suspended periods discontinued time .', 'Dividend HCA today announced Board Directors declared quarterly cash dividend $ 0.72 per share Company ’ common stock .', 'dividend paid March 31 , 2025 stockholders record close business March 17 , 2025 .', '2 declaration payment future dividend subject discretion Board Directors depend variety factors , including Company ’ financial condition , results operations , contractual restrictions .', 'Future dividends expected funded cash balances future cash flows operations .', \"Impact Hurricanes fourth quarter 2024 , Company incurred additional expenses experienced loss revenues estimated $ 200 million , $ 0.60 per diluted share , associated Hurricane Helene 's impact North Carolina facilities , well Hurricane Milton , impacted certain facilities Florida .\", \"year ended December 31 , 2024 , Company incurred additional expenses experienced loss revenues estimated $ 250 million , $ 0.73 per diluted share , associated impact Hurricanes Helene Milton Company 's North Carolina facilities certain facilities Florida .\", 'estimates include insurance recoveries Company may receive .', 'facilities impacted Hurricanes Helene Milton resumed normal operations .', '2025 Guidance Today , Company issued following estimated guidance 2025 : 2025 Guidance Range Revenues $ 72.80 $ 75.80 billion Net Income Attributable HCA Healthcare , Inc. $ 5.85 $ 6.29 billion Adjusted EBITDA $ 14.30 $ 15.10 billion EPS ( diluted ) $ 24.05 $ 25.85 per diluted share Capital expenditures 2025 , excluding acquisitions , estimated approximately $ 5.0 $ 5.2 billion .', 'Company ’ guidance contains number assumptions , including , among others , Company ’ current expectations regarding volume growth coupled anticipated mostly stable operating environment , payer mix , ongoing impacts two major hurricanes , impact current future health care public policy developments , well general economic conditions , including inflation , excludes impact items , limited , gains losses sales facilities , losses retirement debt , legal claims costs impairment long-lived assets .', 'Adjusted EBITDA non-GAAP financial measure .', 'table reconciling forecasted net income attributable HCA Healthcare , Inc. forecasted Adjusted EBITDA included release .', \"Company ’ guidance based current plans expectations subject number known unknown uncertainties risks , including set forth Company ’ “ Forward-Looking Statements. ” 3 Annual Stockholders ' Meeting Company 's 2025 annual stockholders ' meeting held virtually April 24 , 2025 2:00 p.m. Central Time stockholders record February 24 , 2025 .\", 'Earnings Conference Call HCA Healthcare host conference call investors 9:00 a.m. Central Time today .', 'interested investors invited access live audio broadcast call via webcast .', 'broadcast also available replay basis beginning afternoon .', 'webcast accessed Company ’ Investor Relations web page https : //investor.hcahealthcare.com/events-and-presentations/default.aspx .', 'Company December 31 , 2024 , HCA operated 190 hospitals approximately 2,400 ambulatory sites care , including surgery centers , freestanding emergency rooms , urgent care centers physician clinics , 20 states United Kingdom .', 'Forward-Looking Statements press release contains forward-looking statements within meaning federal securities laws , involve risks uncertainties .', 'Forward-looking statements include Company ’ financial guidance year ending December 31 , 2025 , well statements relate solely historical current facts .', 'Forward-looking statements identified use words like “ may , ” “ believe , ” “ , ” “ expect , ” “ project , ” “ estimate , ” “ anticipate , ” “ plan , ” “ initiative ” “ continue. ” forward-looking statements based current plans expectations subject number known unknown uncertainties risks , many beyond control , could significantly affect current plans expectations future financial position results operations .', 'factors include , limited , ( 1 ) changes related general economic conditions nationally regionally markets , including inflation economic business conditions ( impact thereof economy , financial markets banking industry ) ; changes revenues due declining patient volumes ; changes payer mix ( including increases uninsured underinsured patients ) ; potential increased expenses related labor , supply chain expenditures ; workforce disruptions ; supply shortages disruptions ( including result geopolitical disruptions ) ; impact potential federal government shutdowns , ( 2 ) impact significant indebtedness ability refinance indebtedness acceptable terms , ( 3 ) impact current future health care public policy developments possible changes federal , state local laws regulations affecting health care industry , including , limited , expiration enhanced premium tax credits individuals eligible purchase insurance coverage federal state-based health insurance marketplaces , ( 4 ) effects related implementation sequestration spending reductions required Budget Control Act 2011 , related legislation extending reductions , potential future deficit reduction legislation may alter spending reductions , include cuts Medicare payments , create additional spending reductions , ( 5 ) increases amount risk collectability uninsured accounts deductibles copayment amounts insured accounts , ( 6 ) ability achieve operating financial targets , attain expected levels patient volumes revenues , control costs providing services , ( 7 ) possible changes Medicare , Medicaid state programs , including Medicaid supplemental payment programs , Medicaid waiver programs state directed payments , may impact reimbursements 4 health care providers insurers size uninsured underinsured population , ( 8 ) personnel-related capacity constraints , increases wages ability attract , utilize retain qualified management personnel , including affiliated physicians , nurses medical technical support personnel , ( 9 ) highly competitive nature health care business , ( 10 ) changes service mix , revenue mix surgical volumes , including potential declines population covered third-party payer agreements , ability enter renew third-party payer provider agreements acceptable terms impact consumer-driven health plans physician utilization trends practices , ( 11 ) efforts health insurers , health care providers , large employer groups others contain health care costs , ( 12 ) outcome continuing efforts monitor , maintain comply appropriate laws , regulations , policies procedures , ( 13 ) availability terms capital fund expansion business improvements existing facilities , ( 14 ) changes accounting practices , ( 15 ) emergence effects related pandemics , epidemics outbreaks infectious diseases public health crises , ( 16 ) future divestitures may result charges possible impairments long-lived assets , ( 17 ) changes business strategy development plans , ( 18 ) delays receiving payments services provided , ( 19 ) outcome pending future tax audits , disputes litigation associated tax positions , ( 20 ) impact known unknown government investigations , litigation claims may made us , ( 21 ) impact actual potential cybersecurity incidents security breaches involving us vendors third parties , ( 22 ) ongoing ability demonstrate meaningful use certified electronic health record technology impact interoperability requirements , ( 23 ) impact natural disasters , hurricanes floods , including Hurricanes Milton Helene , physical risks climate change similar events beyond control assets activities communities serve , ( 24 ) changes U.S. federal , state , foreign tax laws including interpretive guidance may issued taxing authorities standard setting bodies , ( 25 ) results efforts use technology resilience initiatives , including artificial intelligence machine learning , drive efficiencies , better outcomes enhanced patient experience , ( 26 ) impact recent decisions U.S. Supreme Court regarding actions federal agencies , ( 27 ) risk factors described annual report Form 10-K year ended December 31 , 2023 filings Securities Exchange Commission .', 'Many factors determine future results beyond ability control predict .', 'light significant uncertainties inherent forward-looking statements contained herein , readers place undue reliance forward-looking statements , reflect management ’ views date hereof .', 'undertake obligation revise update forward-looking statements , make forward-looking statements , whether result new information , future events otherwise .', 'references “ Company , ” “ HCA ” “ HCA Healthcare ” used throughout release refer HCA Healthcare , Inc. affiliates .', \"5 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Fourth Quarter Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 18,285 100.0 % $ 17,303 100.0 % Salaries benefits 7,917 43.3 7,570 43.7 Supplies 2,793 15.3 2,584 14.9 operating expenses 3,873 21.2 3,559 20.7 Equity earnings affiliates ( 10 ) ( 0.1 ) ( 28 ) ( 0.2 ) Depreciation amortization 856 4.6 789 4.5 Interest expense 528 2.9 491 2.8 Losses ( gains ) sales facilities 195 1.1 ( 7 ) — 16,152 88.3 14,958 86.4 Income income taxes 2,133 11.7 2,345 13.6 Provision income taxes 447 2.5 484 2.8 Net income 1,686 9.2 1,861 10.8 Net income attributable noncontrolling interests 248 1.3 254 1.5 Net income attributable HCA Healthcare , Inc. $ 1,438 7.9 $ 1,607 9.3 Diluted earnings per share $ 5.63 $ 5.93 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 Comprehensive income attributable HCA Healthcare , Inc. $ 1,429 $ 1,673 6 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 70,603 100.0 % $ 64,968 100.0 % Salaries benefits 31,170 44.1 29,487 45.4 Supplies 10,755 15.2 9,902 15.2 operating expenses 14,819 21.0 12,875 19.8 Equity earnings affiliates ( 23 ) — ( 22 ) — Depreciation amortization 3,312 4.7 3,077 4.7 Interest expense 2,061 2.9 1,938 3.0 Losses ( gains ) sales facilities ( 14 ) — 5 — 62,080 87.9 57,262 88.1 Income income taxes 8,523 12.1 7,706 11.9 Provision income taxes 1,866 2.7 1,615 2.5 Net income 6,657 9.4 6,091 9.4 Net income attributable noncontrolling interests 897 1.2 849 1.3 Net income attributable HCA Healthcare , Inc. $ 5,760 8.2 $ 5,242 8.1 Diluted earnings per share $ 22.00 $ 18.97 Shares used computing diluted earnings per share ( millions ) 261.806 276.412 Comprehensive income attributable HCA Healthcare , Inc. $ 5,798 $ 5,307 7 HCA Healthcare , Inc. Condensed Consolidated Balance Sheets Unaudited ( Dollars millions ) December 31 , September 30 , December 31 , 2024 2024 2023 ASSETS Current assets : Cash cash equivalents $ 1,933 $ 2,888 $ 935 Accounts receivable 10,751 9,915 9,958 Inventories 1,738 1,776 2,021 1,992 2,083 2,013 16,414 16,662 14,927 Property equipment , cost 62,514 61,750 58,548 Accumulated depreciation ( 33,100 ) ( 32,703 ) ( 30,833 ) 29,414 29,047 27,715 Investments insurance subsidiaries 569 553 477 Investments advances affiliates 662 705 756 Goodwill intangible assets 10,093 9,982 9,945 Right-of-use operating lease assets 2,131 2,201 2,207 230 309 184 $ 59,513 $ 59,459 $ 56,211 LIABILITIES STOCKHOLDERS ' EQUITY Current liabilities : Accounts payable $ 4,276 $ 4,235 $ 4,233 Accrued salaries 2,304 2,164 2,127 accrued expenses 3,899 3,819 3,871 Long-term debt due within one year 4,698 4,682 2,424 15,177 14,900 12,655 Long-term debt , less debt issuance costs discounts $ 369 , $ 378 $ 333 38,333 38,283 37,169 Professional liability risks 1,544 1,584 1,557 Right-of-use operating lease obligations 1,863 1,924 1,903 Income taxes liabilities 2,041 1,982 1,867 Stockholders ' equity : Stockholders ' deficit attributable HCA Healthcare , Inc. ( 2,499 ) ( 2,182 ) ( 1,774 ) Noncontrolling interests 3,054 2,968 2,834 555 786 1,060 $ 59,513 $ 59,459 $ 56,211 8 HCA Healthcare , Inc. Condensed Consolidated Statements Cash Flows Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions ) 2024 2023 Cash flows operating activities : Net income $ 6,657 $ 6,091 Adjustments reconcile net income net cash provided operating activities : Increase ( decrease ) cash operating assets liabilities : Accounts receivable ( 799 ) ( 935 ) Inventories assets 334 ( 126 ) Accounts payable accrued expenses 359 604 Depreciation amortization 3,312 3,077 Income taxes 22 229 Losses ( gains ) sales facilities ( 14 ) 5 Amortization debt issuance costs discounts 35 35 Share-based compensation 360 262 248 189 Net cash provided operating activities 10,514 9,431 Cash flows investing activities : Purchase property equipment ( 4,875 ) ( 4,744 ) Acquisition hospitals health care entities ( 266 ) ( 635 ) Sales hospitals health care entities 328 193 Change investments ( 115 ) ( 112 ) ( 5 ) ( 19 ) Net cash used investing activities ( 4,933 ) ( 5,317 ) Cash flows financing activities : Issuances long-term debt 7,495 3,224 Net change revolving credit facilities ( 1,880 ) ( 1,020 ) Repayment long-term debt ( 2,410 ) ( 909 ) Distributions noncontrolling interests ( 711 ) ( 640 ) Payment debt issuance costs ( 67 ) ( 31 ) Payment dividends ( 690 ) ( 661 ) Repurchase common stock ( 6,042 ) ( 3,811 ) ( 277 ) ( 246 ) Net cash used financing activities ( 4,582 ) ( 4,094 ) Effect exchange rate changes cash cash equivalents ( 1 ) 7 Change cash cash equivalents 998 27 Cash cash equivalents beginning period 935 908 Cash cash equivalents end period $ 1,933 $ 935 Interest payments $ 1,938 $ 1,892 Income tax payments , net $ 1,844 $ 1,386 9 HCA Healthcare , Inc. Operating Statistics Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Operations : Number Hospitals 190 186 190 186 Number Freestanding Outpatient Surgery Centers * 124 124 124 124 Licensed Beds End Period 49,985 49,588 49,985 49,588 Weighted Average Beds Service 42,705 42,072 42,633 41,873 Reported : Admissions 559,170 544,554 2,236,595 2,130,728 % Change 2.7 % 5.0 % Equivalent Admissions 1,007,623 974,561 3,990,085 3,788,434 % Change 3.4 % 5.3 % Revenue per Equivalent Admission $ 18,146 $ 17,755 $ 17,695 $ 17,149 % Change 2.2 % 3.2 % Inpatient Revenue per Admission $ 19,737 $ 18,992 $ 19,050 $ 18,201 % Change 3.9 % 4.7 % Patient Days 2,691,710 2,674,331 10,826,574 10,483,236 % Change 0.6 % 3.3 % Equivalent Patient Days 4,850,820 4,786,197 19,314,608 18,639,194 % Change 1.4 % 3.6 % Inpatient Surgery Cases 135,643 132,417 540,704 528,845 % Change 2.4 % 2.2 % Outpatient Surgery Cases 263,832 270,286 1,024,998 1,044,415 % Change -2.4 % -1.9 % Emergency Room Visits 2,498,429 2,452,395 9,789,265 9,342,783 % Change 1.9 % 4.8 % Outpatient Revenues Percentage Patient Revenues 37.9 % 38.4 % 37.8 % 38.3 % Average Length Stay ( days ) 4.814 4.911 4.841 4.920 Occupancy * * 71.7 % 72.5 % 72.7 % 72.3 % Facility : Admissions 552,610 536,350 2,204,148 2,101,839 % Change 3.0 % 4.9 % Equivalent Admissions 980,330 950,949 3,881,505 3,713,950 % Change 3.1 % 4.5 % Revenue per Equivalent Admission $ 18,185 $ 17,674 $ 17,625 $ 17,071 % Change 2.9 % 3.2 % Inpatient Revenue per Admission $ 19,835 $ 19,006 $ 19,085 $ 18,185 % Change 4.4 % 4.9 % Inpatient Surgery Cases 134,482 130,779 534,330 523,074 % Change 2.8 % 2.2 % Outpatient Surgery Cases 257,663 261,155 997,043 1,013,752 % Change -1.3 % -1.6 % Emergency Room Visits 2,466,784 2,410,050 9,642,016 9,192,154 % Change 2.4 % 4.9 % * Excludes freestanding endoscopy centers ( 26 centers December 31 , 2024 24 centers December 31 , 2023 ) .\", '* * Reflects rate occupancy ( patient days observations ) based weighted average beds service .', '10 HCA Healthcare , Inc .', \"Supplemental Non-GAAP Disclosures Operating Results Summary ( Dollars millions , except per share amounts ) Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Revenues $ 18,285 $ 17,303 $ 70,603 $ 64,968 Net income attributable HCA Healthcare , Inc. $ 1,438 $ 1,607 $ 5,760 $ 5,242 Losses ( gains ) sales facilities ( net tax ) 149 ( 9 ) ( 11 ) 12 Net income attributable HCA Healthcare , Inc. , adjusted ( ) 1,587 1,598 5,749 5,254 Depreciation amortization 856 789 3,312 3,077 Interest expense 528 491 2,061 1,938 Provision income taxes 493 486 1,863 1,608 Net income attributable noncontrolling interests 248 254 897 849 Adjusted EBITDA ( ) 3,712 $ 3,618 $ 13,882 $ 12,726 Adjusted EBITDA margin ( ) 20.3 % 20.9 % 19.7 % 19.6 % Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 5.63 $ 5.93 $ 22.00 $ 18.97 Losses ( gains ) sales facilities 0.59 ( 0.03 ) ( 0.04 ) 0.04 Net income attributable HCA Healthcare , Inc. , adjusted ( ) $ 6.22 $ 5.90 $ 21.96 $ 19.01 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 261.806 276.412 ( ) Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA considered measures financial performance generally accepted accounting principles ( `` GAAP '' ) .\", 'non-GAAP financial measures adjusted exclude losses ( gains ) sales facilities losses retirement debt .', 'believe net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA important measures supplement discussions analysis results operations .', 'believe useful investors provide disclosures results operations basis used management .', 'Management relies upon net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA primary measures review assess operating performance health care facilities management teams .', 'Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , GAAP net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) health care facilities .', 'Adjusted EBITDA Adjusted EBITDA margin ( Adjusted EBITDA divided revenues ) utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .', 'reasonable expect adjustments , including losses ( gains ) sales facilities losses retirement debt occur future periods , amounts recognized vary significantly period period , directly relate ongoing operations health care facilities complicate period comparisons results operations operations comparisons health care companies .', 'Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measures financial performance GAAP , considered alternatives net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .', 'net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measurements determined accordance GAAP susceptible varying calculations , net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .', '11 HCA Healthcare , Inc .', \"Supplemental Non-GAAP Disclosures 2025 Operating Results Forecast ( Dollars millions , except per share amounts ) Year Ending December 31 , 2025 Low High Revenues $ 72,800 $ 75,800 Net income attributable HCA Healthcare , Inc. ( ) $ 5,850 $ 6,290 Depreciation amortization 3,495 3,565 Interest expense 2,230 2,320 Provision income taxes 1,800 1,950 Net income attributable noncontrolling interests 925 975 Adjusted EBITDA ( ) ( b ) $ 14,300 $ 15,100 Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 24.05 $ 25.85 Shares used computing diluted earnings per share ( millions ) 243.000 243.000 Company 's forecasted guidance based current plans expectations subject number known unknown uncertainties risks .\", '( ) Company forecast impact items , limited , losses ( gains ) sales facilities , losses retirement debt , legal claim costs ( benefits ) impairments long-lived assets Company believe forecast items sufficient accuracy .', \"( b ) Adjusted EBITDA considered measure financial performance generally accepted accounting principles ( `` GAAP '' ) .\", 'believe Adjusted EBITDA important measure supplements discussions analysis results operations .', 'believe useful investors provide disclosures results operations basis used management .', 'Management relies upon Adjusted EBITDA primary measure review assess operating performance health care facilities management teams .', 'Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) healthcare facilities .', 'Adjusted EBITDA utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .', 'Adjusted EBITDA measure financial performance GAAP considered alternative net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .', 'Adjusted EBITDA measurement determined accordance GAAP susceptible varying calculations , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .', '12']\n"
     ]
    }
   ],
   "execution_count": 5
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:49:29.606743Z",
     "start_time": "2025-02-17T09:46:30.902309Z"
    }
   },
   "cell_type": "code",
   "source": [
    "from transformers import pipeline\n",
    "\n",
    "classifier = pipeline(\"zero-shot-classification\", model=\"facebook/bart-large-mnli\")\n",
    "\n",
    "labels = [\"Strength\", \"Weakness\", \"Opportunity\", \"Threat\"]\n",
    "swot_results = {\"Strengths\": [], \"Weaknesses\": [], \"Opportunities\": [], \"Threats\": []}\n",
    "for sentence in processed_sentences:\n",
    "    result = classifier(sentence, candidate_labels=labels)\n",
    "    label = result['labels'][0]\n",
    "    if label == \"Strength\":\n",
    "        swot_results[\"Strengths\"].append(sentence)\n",
    "    elif label == \"Weakness\":\n",
    "        swot_results[\"Weaknesses\"].append(sentence)\n",
    "    elif label == \"Opportunity\":\n",
    "        swot_results[\"Opportunities\"].append(sentence)\n",
    "    elif label == \"Threat\":\n",
    "        swot_results[\"Threats\"].append(sentence)\n",
    "\n",
    "print(swot_results)\n"
   ],
   "id": "c385eb0a74e4d53e",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Device set to use cpu\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'Strengths': [\"Key fourth quarter metrics ( percentage changes compare 4Q 2024 4Q 2023 unless otherwise noted ) : \\uf0b7 Revenues totaled $ 18.285 billion \\uf0b7 Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share ( includes estimated $ 0.60 per diluted share unfavorable impact Hurricanes Helene Milton ) \\uf0b7 Adjusted EBITDA totaled $ 3.712 billion \\uf0b7 Cash flows operating activities totaled $ 2.559 billion \\uf0b7 facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent '' finished 2024 strong business fundamentals consistent previous quarters , '' said Sam Hazen , Chief Executive Officer HCA Healthcare .\", '`` first half current decade , ended 2024 , proved another period long-term growth company resulted operational improvements across key performance indicators greater value patients , employees shareholders .', \"accomplishments testament incredible work teams , position us well future . ''\", 'Revenues fourth quarter 2024 totaled $ 18.285 billion , compared $ 17.303 billion fourth quarter 2023 .', 'Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share , compared $ 1.607 billion , $ 5.93 per diluted share , fourth quarter 2023 .', 'Results fourth quarter 2023 include gains sales facilities $ 7 million , $ 0.03 per diluted share .', 'Adjusted EBITDA non-GAAP financial measure .', 'facility revenue per equivalent admission increased 2.9 percent fourth quarter 2024 , compared fourth quarter 2023 .', 'Year Ended December 31 , 2024 Revenues year ended December 31 , 2024 totaled $ 70.603 billion , compared $ 64.968 billion year ended December 31 , 2023 .', 'Net income attributable HCA Healthcare , Inc. $ 5.760 billion , $ 22.00 per diluted share , compared $ 5.242 billion , $ 18.97 per diluted share , year ended December 31 , 2023 .', 'Results year ended December 31 , 2024 include gains sales facilities $ 14 million , $ 0.04 per diluted share .', '2024 , Adjusted EBITDA totaled $ 13.882 billion , compared $ 12.726 billion 2023 .', 'Adjusted EBITDA non-GAAP financial measure .', 'fourth quarter 2024 , Company repurchased 4.739 million shares common stock cost $ 1.700 billion .', 'Company $ 764 million remaining repurchase authorization December 31 , 2024 .', 'Share Repurchase Program HCA Healthcare , Inc. Board Directors authorized additional share repurchase program $ 10 billion Company ’ outstanding common stock .', 'Dividend HCA today announced Board Directors declared quarterly cash dividend $ 0.72 per share Company ’ common stock .', 'dividend paid March 31 , 2025 stockholders record close business March 17 , 2025 .', '2 declaration payment future dividend subject discretion Board Directors depend variety factors , including Company ’ financial condition , results operations , contractual restrictions .', 'Future dividends expected funded cash balances future cash flows operations .', 'Adjusted EBITDA non-GAAP financial measure .', \"Company ’ guidance based current plans expectations subject number known unknown uncertainties risks , including set forth Company ’ “ Forward-Looking Statements. ” 3 Annual Stockholders ' Meeting Company 's 2025 annual stockholders ' meeting held virtually April 24 , 2025 2:00 p.m. Central Time stockholders record February 24 , 2025 .\", 'webcast accessed Company ’ Investor Relations web page https : //investor.hcahealthcare.com/events-and-presentations/default.aspx .', 'Company December 31 , 2024 , HCA operated 190 hospitals approximately 2,400 ambulatory sites care , including surgery centers , freestanding emergency rooms , urgent care centers physician clinics , 20 states United Kingdom .', 'references “ Company , ” “ HCA ” “ HCA Healthcare ” used throughout release refer HCA Healthcare , Inc. affiliates .', '* * Reflects rate occupancy ( patient days observations ) based weighted average beds service .', '10 HCA Healthcare , Inc .', 'believe net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA important measures supplement discussions analysis results operations .', 'believe useful investors provide disclosures results operations basis used management .', 'Management relies upon net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA primary measures review assess operating performance health care facilities management teams .', 'Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measures financial performance GAAP , considered alternatives net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .', '11 HCA Healthcare , Inc .', \"( b ) Adjusted EBITDA considered measure financial performance generally accepted accounting principles ( `` GAAP '' ) .\", 'believe Adjusted EBITDA important measure supplements discussions analysis results operations .', 'believe useful investors provide disclosures results operations basis used management .', 'Management relies upon Adjusted EBITDA primary measure review assess operating performance health care facilities management teams .', 'Adjusted EBITDA measure financial performance GAAP considered alternative net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .'], 'Weaknesses': ['IMMEDIATE RELEASE INVESTOR CONTACT : MEDIA CONTACT : Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS PROVIDES 2025 GUIDANCE Nashville , Tenn. , January 24 , 2025 – HCA Healthcare , Inc. ( NYSE : HCA ) today announced financial operating results fourth quarter ended December 31 , 2024 .', 'Results fourth quarter 2024 include losses sales facilities $ 195 million , $ 0.59 per diluted share , primarily related pending sale hospital facility California .', 'fourth quarter 2024 , Adjusted EBITDA totaled $ 3.712 billion , compared $ 3.618 billion fourth quarter 2023 .', 'facility emergency room visits increased 2.4 percent fourth quarter 2024 , compared prior year period .', 'facility inpatient surgeries increased 2.8 percent , facility outpatient surgeries declined 1.3 percent fourth quarter 2024 , compared period 2023 .', 'Results year ended December 31 , 2023 included losses sales facilities $ 5 million , $ 0.04 per diluted share .', 'Balance Sheet Cash Flows Operations December 31 , 2024 , HCA Healthcare , Inc. ’ balance sheet reflected cash cash equivalents $ 1.933 billion , total debt $ 43.031 billion , total assets $ 59.513 billion .', 'fourth quarter 2024 , capital expenditures totaled $ 1.285 billion , excluding acquisitions .', 'Cash flows provided operating activities fourth quarter 2024 totaled $ 2.559 billion , compared $ 2.674 billion fourth quarter 2023 .', \"year ended December 31 , 2024 , Company incurred additional expenses experienced loss revenues estimated $ 250 million , $ 0.73 per diluted share , associated impact Hurricanes Helene Milton Company 's North Carolina facilities certain facilities Florida .\", 'facilities impacted Hurricanes Helene Milton resumed normal operations .', '2025 Guidance Today , Company issued following estimated guidance 2025 : 2025 Guidance Range Revenues $ 72.80 $ 75.80 billion Net Income Attributable HCA Healthcare , Inc. $ 5.85 $ 6.29 billion Adjusted EBITDA $ 14.30 $ 15.10 billion EPS ( diluted ) $ 24.05 $ 25.85 per diluted share Capital expenditures 2025 , excluding acquisitions , estimated approximately $ 5.0 $ 5.2 billion .', 'Company ’ guidance contains number assumptions , including , among others , Company ’ current expectations regarding volume growth coupled anticipated mostly stable operating environment , payer mix , ongoing impacts two major hurricanes , impact current future health care public policy developments , well general economic conditions , including inflation , excludes impact items , limited , gains losses sales facilities , losses retirement debt , legal claims costs impairment long-lived assets .', 'Earnings Conference Call HCA Healthcare host conference call investors 9:00 a.m. Central Time today .', 'Forward-looking statements include Company ’ financial guidance year ending December 31 , 2025 , well statements relate solely historical current facts .', \"5 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Fourth Quarter Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 18,285 100.0 % $ 17,303 100.0 % Salaries benefits 7,917 43.3 7,570 43.7 Supplies 2,793 15.3 2,584 14.9 operating expenses 3,873 21.2 3,559 20.7 Equity earnings affiliates ( 10 ) ( 0.1 ) ( 28 ) ( 0.2 ) Depreciation amortization 856 4.6 789 4.5 Interest expense 528 2.9 491 2.8 Losses ( gains ) sales facilities 195 1.1 ( 7 ) — 16,152 88.3 14,958 86.4 Income income taxes 2,133 11.7 2,345 13.6 Provision income taxes 447 2.5 484 2.8 Net income 1,686 9.2 1,861 10.8 Net income attributable noncontrolling interests 248 1.3 254 1.5 Net income attributable HCA Healthcare , Inc. $ 1,438 7.9 $ 1,607 9.3 Diluted earnings per share $ 5.63 $ 5.93 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 Comprehensive income attributable HCA Healthcare , Inc. $ 1,429 $ 1,673 6 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 70,603 100.0 % $ 64,968 100.0 % Salaries benefits 31,170 44.1 29,487 45.4 Supplies 10,755 15.2 9,902 15.2 operating expenses 14,819 21.0 12,875 19.8 Equity earnings affiliates ( 23 ) — ( 22 ) — Depreciation amortization 3,312 4.7 3,077 4.7 Interest expense 2,061 2.9 1,938 3.0 Losses ( gains ) sales facilities ( 14 ) — 5 — 62,080 87.9 57,262 88.1 Income income taxes 8,523 12.1 7,706 11.9 Provision income taxes 1,866 2.7 1,615 2.5 Net income 6,657 9.4 6,091 9.4 Net income attributable noncontrolling interests 897 1.2 849 1.3 Net income attributable HCA Healthcare , Inc. $ 5,760 8.2 $ 5,242 8.1 Diluted earnings per share $ 22.00 $ 18.97 Shares used computing diluted earnings per share ( millions ) 261.806 276.412 Comprehensive income attributable HCA Healthcare , Inc. $ 5,798 $ 5,307 7 HCA Healthcare , Inc. Condensed Consolidated Balance Sheets Unaudited ( Dollars millions ) December 31 , September 30 , December 31 , 2024 2024 2023 ASSETS Current assets : Cash cash equivalents $ 1,933 $ 2,888 $ 935 Accounts receivable 10,751 9,915 9,958 Inventories 1,738 1,776 2,021 1,992 2,083 2,013 16,414 16,662 14,927 Property equipment , cost 62,514 61,750 58,548 Accumulated depreciation ( 33,100 ) ( 32,703 ) ( 30,833 ) 29,414 29,047 27,715 Investments insurance subsidiaries 569 553 477 Investments advances affiliates 662 705 756 Goodwill intangible assets 10,093 9,982 9,945 Right-of-use operating lease assets 2,131 2,201 2,207 230 309 184 $ 59,513 $ 59,459 $ 56,211 LIABILITIES STOCKHOLDERS ' EQUITY Current liabilities : Accounts payable $ 4,276 $ 4,235 $ 4,233 Accrued salaries 2,304 2,164 2,127 accrued expenses 3,899 3,819 3,871 Long-term debt due within one year 4,698 4,682 2,424 15,177 14,900 12,655 Long-term debt , less debt issuance costs discounts $ 369 , $ 378 $ 333 38,333 38,283 37,169 Professional liability risks 1,544 1,584 1,557 Right-of-use operating lease obligations 1,863 1,924 1,903 Income taxes liabilities 2,041 1,982 1,867 Stockholders ' equity : Stockholders ' deficit attributable HCA Healthcare , Inc. ( 2,499 ) ( 2,182 ) ( 1,774 ) Noncontrolling interests 3,054 2,968 2,834 555 786 1,060 $ 59,513 $ 59,459 $ 56,211 8 HCA Healthcare , Inc. Condensed Consolidated Statements Cash Flows Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions ) 2024 2023 Cash flows operating activities : Net income $ 6,657 $ 6,091 Adjustments reconcile net income net cash provided operating activities : Increase ( decrease ) cash operating assets liabilities : Accounts receivable ( 799 ) ( 935 ) Inventories assets 334 ( 126 ) Accounts payable accrued expenses 359 604 Depreciation amortization 3,312 3,077 Income taxes 22 229 Losses ( gains ) sales facilities ( 14 ) 5 Amortization debt issuance costs discounts 35 35 Share-based compensation 360 262 248 189 Net cash provided operating activities 10,514 9,431 Cash flows investing activities : Purchase property equipment ( 4,875 ) ( 4,744 ) Acquisition hospitals health care entities ( 266 ) ( 635 ) Sales hospitals health care entities 328 193 Change investments ( 115 ) ( 112 ) ( 5 ) ( 19 ) Net cash used investing activities ( 4,933 ) ( 5,317 ) Cash flows financing activities : Issuances long-term debt 7,495 3,224 Net change revolving credit facilities ( 1,880 ) ( 1,020 ) Repayment long-term debt ( 2,410 ) ( 909 ) Distributions noncontrolling interests ( 711 ) ( 640 ) Payment debt issuance costs ( 67 ) ( 31 ) Payment dividends ( 690 ) ( 661 ) Repurchase common stock ( 6,042 ) ( 3,811 ) ( 277 ) ( 246 ) Net cash used financing activities ( 4,582 ) ( 4,094 ) Effect exchange rate changes cash cash equivalents ( 1 ) 7 Change cash cash equivalents 998 27 Cash cash equivalents beginning period 935 908 Cash cash equivalents end period $ 1,933 $ 935 Interest payments $ 1,938 $ 1,892 Income tax payments , net $ 1,844 $ 1,386 9 HCA Healthcare , Inc. Operating Statistics Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Operations : Number Hospitals 190 186 190 186 Number Freestanding Outpatient Surgery Centers * 124 124 124 124 Licensed Beds End Period 49,985 49,588 49,985 49,588 Weighted Average Beds Service 42,705 42,072 42,633 41,873 Reported : Admissions 559,170 544,554 2,236,595 2,130,728 % Change 2.7 % 5.0 % Equivalent Admissions 1,007,623 974,561 3,990,085 3,788,434 % Change 3.4 % 5.3 % Revenue per Equivalent Admission $ 18,146 $ 17,755 $ 17,695 $ 17,149 % Change 2.2 % 3.2 % Inpatient Revenue per Admission $ 19,737 $ 18,992 $ 19,050 $ 18,201 % Change 3.9 % 4.7 % Patient Days 2,691,710 2,674,331 10,826,574 10,483,236 % Change 0.6 % 3.3 % Equivalent Patient Days 4,850,820 4,786,197 19,314,608 18,639,194 % Change 1.4 % 3.6 % Inpatient Surgery Cases 135,643 132,417 540,704 528,845 % Change 2.4 % 2.2 % Outpatient Surgery Cases 263,832 270,286 1,024,998 1,044,415 % Change -2.4 % -1.9 % Emergency Room Visits 2,498,429 2,452,395 9,789,265 9,342,783 % Change 1.9 % 4.8 % Outpatient Revenues Percentage Patient Revenues 37.9 % 38.4 % 37.8 % 38.3 % Average Length Stay ( days ) 4.814 4.911 4.841 4.920 Occupancy * * 71.7 % 72.5 % 72.7 % 72.3 % Facility : Admissions 552,610 536,350 2,204,148 2,101,839 % Change 3.0 % 4.9 % Equivalent Admissions 980,330 950,949 3,881,505 3,713,950 % Change 3.1 % 4.5 % Revenue per Equivalent Admission $ 18,185 $ 17,674 $ 17,625 $ 17,071 % Change 2.9 % 3.2 % Inpatient Revenue per Admission $ 19,835 $ 19,006 $ 19,085 $ 18,185 % Change 4.4 % 4.9 % Inpatient Surgery Cases 134,482 130,779 534,330 523,074 % Change 2.8 % 2.2 % Outpatient Surgery Cases 257,663 261,155 997,043 1,013,752 % Change -1.3 % -1.6 % Emergency Room Visits 2,466,784 2,410,050 9,642,016 9,192,154 % Change 2.4 % 4.9 % * Excludes freestanding endoscopy centers ( 26 centers December 31 , 2024 24 centers December 31 , 2023 ) .\", \"Supplemental Non-GAAP Disclosures Operating Results Summary ( Dollars millions , except per share amounts ) Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Revenues $ 18,285 $ 17,303 $ 70,603 $ 64,968 Net income attributable HCA Healthcare , Inc. $ 1,438 $ 1,607 $ 5,760 $ 5,242 Losses ( gains ) sales facilities ( net tax ) 149 ( 9 ) ( 11 ) 12 Net income attributable HCA Healthcare , Inc. , adjusted ( ) 1,587 1,598 5,749 5,254 Depreciation amortization 856 789 3,312 3,077 Interest expense 528 491 2,061 1,938 Provision income taxes 493 486 1,863 1,608 Net income attributable noncontrolling interests 248 254 897 849 Adjusted EBITDA ( ) 3,712 $ 3,618 $ 13,882 $ 12,726 Adjusted EBITDA margin ( ) 20.3 % 20.9 % 19.7 % 19.6 % Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 5.63 $ 5.93 $ 22.00 $ 18.97 Losses ( gains ) sales facilities 0.59 ( 0.03 ) ( 0.04 ) 0.04 Net income attributable HCA Healthcare , Inc. , adjusted ( ) $ 6.22 $ 5.90 $ 21.96 $ 19.01 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 261.806 276.412 ( ) Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA considered measures financial performance generally accepted accounting principles ( `` GAAP '' ) .\", 'non-GAAP financial measures adjusted exclude losses ( gains ) sales facilities losses retirement debt .', 'reasonable expect adjustments , including losses ( gains ) sales facilities losses retirement debt occur future periods , amounts recognized vary significantly period period , directly relate ongoing operations health care facilities complicate period comparisons results operations operations comparisons health care companies .', \"Supplemental Non-GAAP Disclosures 2025 Operating Results Forecast ( Dollars millions , except per share amounts ) Year Ending December 31 , 2025 Low High Revenues $ 72,800 $ 75,800 Net income attributable HCA Healthcare , Inc. ( ) $ 5,850 $ 6,290 Depreciation amortization 3,495 3,565 Interest expense 2,230 2,320 Provision income taxes 1,800 1,950 Net income attributable noncontrolling interests 925 975 Adjusted EBITDA ( ) ( b ) $ 14,300 $ 15,100 Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 24.05 $ 25.85 Shares used computing diluted earnings per share ( millions ) 243.000 243.000 Company 's forecasted guidance based current plans expectations subject number known unknown uncertainties risks .\", '( ) Company forecast impact items , limited , losses ( gains ) sales facilities , losses retirement debt , legal claim costs ( benefits ) impairments long-lived assets Company believe forecast items sufficient accuracy .', '12'], 'Opportunities': ['table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .', '1 facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent fourth quarter 2024 , compared prior year period .', 'table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .', 'Repurchases made accordance applicable securities laws may made management ’ discretion time time open market , privately negotiated transactions , otherwise .', 'estimates include insurance recoveries Company may receive .', 'table reconciling forecasted net income attributable HCA Healthcare , Inc. forecasted Adjusted EBITDA included release .', 'interested investors invited access live audio broadcast call via webcast .', 'broadcast also available replay basis beginning afternoon .', 'Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , GAAP net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) health care facilities .', 'Adjusted EBITDA Adjusted EBITDA margin ( Adjusted EBITDA divided revenues ) utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .', 'net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measurements determined accordance GAAP susceptible varying calculations , net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .', 'Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) healthcare facilities .', 'Adjusted EBITDA utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .', 'Adjusted EBITDA measurement determined accordance GAAP susceptible varying calculations , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .'], 'Threats': ['December 31 , 2024 , Company $ 7.986 billion availability credit facilities .', 'repurchase program time limit may suspended periods discontinued time .', \"Impact Hurricanes fourth quarter 2024 , Company incurred additional expenses experienced loss revenues estimated $ 200 million , $ 0.60 per diluted share , associated Hurricane Helene 's impact North Carolina facilities , well Hurricane Milton , impacted certain facilities Florida .\", 'Forward-Looking Statements press release contains forward-looking statements within meaning federal securities laws , involve risks uncertainties .', 'Forward-looking statements identified use words like “ may , ” “ believe , ” “ , ” “ expect , ” “ project , ” “ estimate , ” “ anticipate , ” “ plan , ” “ initiative ” “ continue. ” forward-looking statements based current plans expectations subject number known unknown uncertainties risks , many beyond control , could significantly affect current plans expectations future financial position results operations .', 'factors include , limited , ( 1 ) changes related general economic conditions nationally regionally markets , including inflation economic business conditions ( impact thereof economy , financial markets banking industry ) ; changes revenues due declining patient volumes ; changes payer mix ( including increases uninsured underinsured patients ) ; potential increased expenses related labor , supply chain expenditures ; workforce disruptions ; supply shortages disruptions ( including result geopolitical disruptions ) ; impact potential federal government shutdowns , ( 2 ) impact significant indebtedness ability refinance indebtedness acceptable terms , ( 3 ) impact current future health care public policy developments possible changes federal , state local laws regulations affecting health care industry , including , limited , expiration enhanced premium tax credits individuals eligible purchase insurance coverage federal state-based health insurance marketplaces , ( 4 ) effects related implementation sequestration spending reductions required Budget Control Act 2011 , related legislation extending reductions , potential future deficit reduction legislation may alter spending reductions , include cuts Medicare payments , create additional spending reductions , ( 5 ) increases amount risk collectability uninsured accounts deductibles copayment amounts insured accounts , ( 6 ) ability achieve operating financial targets , attain expected levels patient volumes revenues , control costs providing services , ( 7 ) possible changes Medicare , Medicaid state programs , including Medicaid supplemental payment programs , Medicaid waiver programs state directed payments , may impact reimbursements 4 health care providers insurers size uninsured underinsured population , ( 8 ) personnel-related capacity constraints , increases wages ability attract , utilize retain qualified management personnel , including affiliated physicians , nurses medical technical support personnel , ( 9 ) highly competitive nature health care business , ( 10 ) changes service mix , revenue mix surgical volumes , including potential declines population covered third-party payer agreements , ability enter renew third-party payer provider agreements acceptable terms impact consumer-driven health plans physician utilization trends practices , ( 11 ) efforts health insurers , health care providers , large employer groups others contain health care costs , ( 12 ) outcome continuing efforts monitor , maintain comply appropriate laws , regulations , policies procedures , ( 13 ) availability terms capital fund expansion business improvements existing facilities , ( 14 ) changes accounting practices , ( 15 ) emergence effects related pandemics , epidemics outbreaks infectious diseases public health crises , ( 16 ) future divestitures may result charges possible impairments long-lived assets , ( 17 ) changes business strategy development plans , ( 18 ) delays receiving payments services provided , ( 19 ) outcome pending future tax audits , disputes litigation associated tax positions , ( 20 ) impact known unknown government investigations , litigation claims may made us , ( 21 ) impact actual potential cybersecurity incidents security breaches involving us vendors third parties , ( 22 ) ongoing ability demonstrate meaningful use certified electronic health record technology impact interoperability requirements , ( 23 ) impact natural disasters , hurricanes floods , including Hurricanes Milton Helene , physical risks climate change similar events beyond control assets activities communities serve , ( 24 ) changes U.S. federal , state , foreign tax laws including interpretive guidance may issued taxing authorities standard setting bodies , ( 25 ) results efforts use technology resilience initiatives , including artificial intelligence machine learning , drive efficiencies , better outcomes enhanced patient experience , ( 26 ) impact recent decisions U.S. Supreme Court regarding actions federal agencies , ( 27 ) risk factors described annual report Form 10-K year ended December 31 , 2023 filings Securities Exchange Commission .', 'Many factors determine future results beyond ability control predict .', 'light significant uncertainties inherent forward-looking statements contained herein , readers place undue reliance forward-looking statements , reflect management ’ views date hereof .', 'undertake obligation revise update forward-looking statements , make forward-looking statements , whether result new information , future events otherwise .']}\n"
     ]
    }
   ],
   "execution_count": 6
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:49:29.667885Z",
     "start_time": "2025-02-17T09:49:29.655975Z"
    }
   },
   "cell_type": "code",
   "source": [
    "def display_swot_results(swot_results):\n",
    "    for category, sentences in swot_results.items():\n",
    "        print(f\"\\n{category}:\\n\")\n",
    "        for sentence in sentences:\n",
    "            print(f\"- {sentence}\")\n",
    "\n",
    "display_swot_results(swot_results)\n"
   ],
   "id": "842d6a68d5268705",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Strengths:\n",
      "\n",
      "- Key fourth quarter metrics ( percentage changes compare 4Q 2024 4Q 2023 unless otherwise noted ) :  Revenues totaled $ 18.285 billion  Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share ( includes estimated $ 0.60 per diluted share unfavorable impact Hurricanes Helene Milton )  Adjusted EBITDA totaled $ 3.712 billion  Cash flows operating activities totaled $ 2.559 billion  facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent '' finished 2024 strong business fundamentals consistent previous quarters , '' said Sam Hazen , Chief Executive Officer HCA Healthcare .\n",
      "- `` first half current decade , ended 2024 , proved another period long-term growth company resulted operational improvements across key performance indicators greater value patients , employees shareholders .\n",
      "- accomplishments testament incredible work teams , position us well future . ''\n",
      "- Revenues fourth quarter 2024 totaled $ 18.285 billion , compared $ 17.303 billion fourth quarter 2023 .\n",
      "- Net income attributable HCA Healthcare , Inc. totaled $ 1.438 billion , $ 5.63 per diluted share , compared $ 1.607 billion , $ 5.93 per diluted share , fourth quarter 2023 .\n",
      "- Results fourth quarter 2023 include gains sales facilities $ 7 million , $ 0.03 per diluted share .\n",
      "- Adjusted EBITDA non-GAAP financial measure .\n",
      "- facility revenue per equivalent admission increased 2.9 percent fourth quarter 2024 , compared fourth quarter 2023 .\n",
      "- Year Ended December 31 , 2024 Revenues year ended December 31 , 2024 totaled $ 70.603 billion , compared $ 64.968 billion year ended December 31 , 2023 .\n",
      "- Net income attributable HCA Healthcare , Inc. $ 5.760 billion , $ 22.00 per diluted share , compared $ 5.242 billion , $ 18.97 per diluted share , year ended December 31 , 2023 .\n",
      "- Results year ended December 31 , 2024 include gains sales facilities $ 14 million , $ 0.04 per diluted share .\n",
      "- 2024 , Adjusted EBITDA totaled $ 13.882 billion , compared $ 12.726 billion 2023 .\n",
      "- Adjusted EBITDA non-GAAP financial measure .\n",
      "- fourth quarter 2024 , Company repurchased 4.739 million shares common stock cost $ 1.700 billion .\n",
      "- Company $ 764 million remaining repurchase authorization December 31 , 2024 .\n",
      "- Share Repurchase Program HCA Healthcare , Inc. Board Directors authorized additional share repurchase program $ 10 billion Company ’ outstanding common stock .\n",
      "- Dividend HCA today announced Board Directors declared quarterly cash dividend $ 0.72 per share Company ’ common stock .\n",
      "- dividend paid March 31 , 2025 stockholders record close business March 17 , 2025 .\n",
      "- 2 declaration payment future dividend subject discretion Board Directors depend variety factors , including Company ’ financial condition , results operations , contractual restrictions .\n",
      "- Future dividends expected funded cash balances future cash flows operations .\n",
      "- Adjusted EBITDA non-GAAP financial measure .\n",
      "- Company ’ guidance based current plans expectations subject number known unknown uncertainties risks , including set forth Company ’ “ Forward-Looking Statements. ” 3 Annual Stockholders ' Meeting Company 's 2025 annual stockholders ' meeting held virtually April 24 , 2025 2:00 p.m. Central Time stockholders record February 24 , 2025 .\n",
      "- webcast accessed Company ’ Investor Relations web page https : //investor.hcahealthcare.com/events-and-presentations/default.aspx .\n",
      "- Company December 31 , 2024 , HCA operated 190 hospitals approximately 2,400 ambulatory sites care , including surgery centers , freestanding emergency rooms , urgent care centers physician clinics , 20 states United Kingdom .\n",
      "- references “ Company , ” “ HCA ” “ HCA Healthcare ” used throughout release refer HCA Healthcare , Inc. affiliates .\n",
      "- * * Reflects rate occupancy ( patient days observations ) based weighted average beds service .\n",
      "- 10 HCA Healthcare , Inc .\n",
      "- believe net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA important measures supplement discussions analysis results operations .\n",
      "- believe useful investors provide disclosures results operations basis used management .\n",
      "- Management relies upon net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA primary measures review assess operating performance health care facilities management teams .\n",
      "- Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measures financial performance GAAP , considered alternatives net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .\n",
      "- 11 HCA Healthcare , Inc .\n",
      "- ( b ) Adjusted EBITDA considered measure financial performance generally accepted accounting principles ( `` GAAP '' ) .\n",
      "- believe Adjusted EBITDA important measure supplements discussions analysis results operations .\n",
      "- believe useful investors provide disclosures results operations basis used management .\n",
      "- Management relies upon Adjusted EBITDA primary measure review assess operating performance health care facilities management teams .\n",
      "- Adjusted EBITDA measure financial performance GAAP considered alternative net income attributable HCA Healthcare , Inc. measure operating performance cash flows operating , investing financing activities measure liquidity .\n",
      "\n",
      "Weaknesses:\n",
      "\n",
      "- IMMEDIATE RELEASE INVESTOR CONTACT : MEDIA CONTACT : Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS PROVIDES 2025 GUIDANCE Nashville , Tenn. , January 24 , 2025 – HCA Healthcare , Inc. ( NYSE : HCA ) today announced financial operating results fourth quarter ended December 31 , 2024 .\n",
      "- Results fourth quarter 2024 include losses sales facilities $ 195 million , $ 0.59 per diluted share , primarily related pending sale hospital facility California .\n",
      "- fourth quarter 2024 , Adjusted EBITDA totaled $ 3.712 billion , compared $ 3.618 billion fourth quarter 2023 .\n",
      "- facility emergency room visits increased 2.4 percent fourth quarter 2024 , compared prior year period .\n",
      "- facility inpatient surgeries increased 2.8 percent , facility outpatient surgeries declined 1.3 percent fourth quarter 2024 , compared period 2023 .\n",
      "- Results year ended December 31 , 2023 included losses sales facilities $ 5 million , $ 0.04 per diluted share .\n",
      "- Balance Sheet Cash Flows Operations December 31 , 2024 , HCA Healthcare , Inc. ’ balance sheet reflected cash cash equivalents $ 1.933 billion , total debt $ 43.031 billion , total assets $ 59.513 billion .\n",
      "- fourth quarter 2024 , capital expenditures totaled $ 1.285 billion , excluding acquisitions .\n",
      "- Cash flows provided operating activities fourth quarter 2024 totaled $ 2.559 billion , compared $ 2.674 billion fourth quarter 2023 .\n",
      "- year ended December 31 , 2024 , Company incurred additional expenses experienced loss revenues estimated $ 250 million , $ 0.73 per diluted share , associated impact Hurricanes Helene Milton Company 's North Carolina facilities certain facilities Florida .\n",
      "- facilities impacted Hurricanes Helene Milton resumed normal operations .\n",
      "- 2025 Guidance Today , Company issued following estimated guidance 2025 : 2025 Guidance Range Revenues $ 72.80 $ 75.80 billion Net Income Attributable HCA Healthcare , Inc. $ 5.85 $ 6.29 billion Adjusted EBITDA $ 14.30 $ 15.10 billion EPS ( diluted ) $ 24.05 $ 25.85 per diluted share Capital expenditures 2025 , excluding acquisitions , estimated approximately $ 5.0 $ 5.2 billion .\n",
      "- Company ’ guidance contains number assumptions , including , among others , Company ’ current expectations regarding volume growth coupled anticipated mostly stable operating environment , payer mix , ongoing impacts two major hurricanes , impact current future health care public policy developments , well general economic conditions , including inflation , excludes impact items , limited , gains losses sales facilities , losses retirement debt , legal claims costs impairment long-lived assets .\n",
      "- Earnings Conference Call HCA Healthcare host conference call investors 9:00 a.m. Central Time today .\n",
      "- Forward-looking statements include Company ’ financial guidance year ending December 31 , 2025 , well statements relate solely historical current facts .\n",
      "- 5 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Fourth Quarter Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 18,285 100.0 % $ 17,303 100.0 % Salaries benefits 7,917 43.3 7,570 43.7 Supplies 2,793 15.3 2,584 14.9 operating expenses 3,873 21.2 3,559 20.7 Equity earnings affiliates ( 10 ) ( 0.1 ) ( 28 ) ( 0.2 ) Depreciation amortization 856 4.6 789 4.5 Interest expense 528 2.9 491 2.8 Losses ( gains ) sales facilities 195 1.1 ( 7 ) — 16,152 88.3 14,958 86.4 Income income taxes 2,133 11.7 2,345 13.6 Provision income taxes 447 2.5 484 2.8 Net income 1,686 9.2 1,861 10.8 Net income attributable noncontrolling interests 248 1.3 254 1.5 Net income attributable HCA Healthcare , Inc. $ 1,438 7.9 $ 1,607 9.3 Diluted earnings per share $ 5.63 $ 5.93 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 Comprehensive income attributable HCA Healthcare , Inc. $ 1,429 $ 1,673 6 HCA Healthcare , Inc. Condensed Consolidated Comprehensive Income Statements Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions , except per share amounts ) 2024 2023 Amount Ratio Amount Ratio Revenues $ 70,603 100.0 % $ 64,968 100.0 % Salaries benefits 31,170 44.1 29,487 45.4 Supplies 10,755 15.2 9,902 15.2 operating expenses 14,819 21.0 12,875 19.8 Equity earnings affiliates ( 23 ) — ( 22 ) — Depreciation amortization 3,312 4.7 3,077 4.7 Interest expense 2,061 2.9 1,938 3.0 Losses ( gains ) sales facilities ( 14 ) — 5 — 62,080 87.9 57,262 88.1 Income income taxes 8,523 12.1 7,706 11.9 Provision income taxes 1,866 2.7 1,615 2.5 Net income 6,657 9.4 6,091 9.4 Net income attributable noncontrolling interests 897 1.2 849 1.3 Net income attributable HCA Healthcare , Inc. $ 5,760 8.2 $ 5,242 8.1 Diluted earnings per share $ 22.00 $ 18.97 Shares used computing diluted earnings per share ( millions ) 261.806 276.412 Comprehensive income attributable HCA Healthcare , Inc. $ 5,798 $ 5,307 7 HCA Healthcare , Inc. Condensed Consolidated Balance Sheets Unaudited ( Dollars millions ) December 31 , September 30 , December 31 , 2024 2024 2023 ASSETS Current assets : Cash cash equivalents $ 1,933 $ 2,888 $ 935 Accounts receivable 10,751 9,915 9,958 Inventories 1,738 1,776 2,021 1,992 2,083 2,013 16,414 16,662 14,927 Property equipment , cost 62,514 61,750 58,548 Accumulated depreciation ( 33,100 ) ( 32,703 ) ( 30,833 ) 29,414 29,047 27,715 Investments insurance subsidiaries 569 553 477 Investments advances affiliates 662 705 756 Goodwill intangible assets 10,093 9,982 9,945 Right-of-use operating lease assets 2,131 2,201 2,207 230 309 184 $ 59,513 $ 59,459 $ 56,211 LIABILITIES STOCKHOLDERS ' EQUITY Current liabilities : Accounts payable $ 4,276 $ 4,235 $ 4,233 Accrued salaries 2,304 2,164 2,127 accrued expenses 3,899 3,819 3,871 Long-term debt due within one year 4,698 4,682 2,424 15,177 14,900 12,655 Long-term debt , less debt issuance costs discounts $ 369 , $ 378 $ 333 38,333 38,283 37,169 Professional liability risks 1,544 1,584 1,557 Right-of-use operating lease obligations 1,863 1,924 1,903 Income taxes liabilities 2,041 1,982 1,867 Stockholders ' equity : Stockholders ' deficit attributable HCA Healthcare , Inc. ( 2,499 ) ( 2,182 ) ( 1,774 ) Noncontrolling interests 3,054 2,968 2,834 555 786 1,060 $ 59,513 $ 59,459 $ 56,211 8 HCA Healthcare , Inc. Condensed Consolidated Statements Cash Flows Years Ended December 31 , 2024 2023 Unaudited ( Dollars millions ) 2024 2023 Cash flows operating activities : Net income $ 6,657 $ 6,091 Adjustments reconcile net income net cash provided operating activities : Increase ( decrease ) cash operating assets liabilities : Accounts receivable ( 799 ) ( 935 ) Inventories assets 334 ( 126 ) Accounts payable accrued expenses 359 604 Depreciation amortization 3,312 3,077 Income taxes 22 229 Losses ( gains ) sales facilities ( 14 ) 5 Amortization debt issuance costs discounts 35 35 Share-based compensation 360 262 248 189 Net cash provided operating activities 10,514 9,431 Cash flows investing activities : Purchase property equipment ( 4,875 ) ( 4,744 ) Acquisition hospitals health care entities ( 266 ) ( 635 ) Sales hospitals health care entities 328 193 Change investments ( 115 ) ( 112 ) ( 5 ) ( 19 ) Net cash used investing activities ( 4,933 ) ( 5,317 ) Cash flows financing activities : Issuances long-term debt 7,495 3,224 Net change revolving credit facilities ( 1,880 ) ( 1,020 ) Repayment long-term debt ( 2,410 ) ( 909 ) Distributions noncontrolling interests ( 711 ) ( 640 ) Payment debt issuance costs ( 67 ) ( 31 ) Payment dividends ( 690 ) ( 661 ) Repurchase common stock ( 6,042 ) ( 3,811 ) ( 277 ) ( 246 ) Net cash used financing activities ( 4,582 ) ( 4,094 ) Effect exchange rate changes cash cash equivalents ( 1 ) 7 Change cash cash equivalents 998 27 Cash cash equivalents beginning period 935 908 Cash cash equivalents end period $ 1,933 $ 935 Interest payments $ 1,938 $ 1,892 Income tax payments , net $ 1,844 $ 1,386 9 HCA Healthcare , Inc. Operating Statistics Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Operations : Number Hospitals 190 186 190 186 Number Freestanding Outpatient Surgery Centers * 124 124 124 124 Licensed Beds End Period 49,985 49,588 49,985 49,588 Weighted Average Beds Service 42,705 42,072 42,633 41,873 Reported : Admissions 559,170 544,554 2,236,595 2,130,728 % Change 2.7 % 5.0 % Equivalent Admissions 1,007,623 974,561 3,990,085 3,788,434 % Change 3.4 % 5.3 % Revenue per Equivalent Admission $ 18,146 $ 17,755 $ 17,695 $ 17,149 % Change 2.2 % 3.2 % Inpatient Revenue per Admission $ 19,737 $ 18,992 $ 19,050 $ 18,201 % Change 3.9 % 4.7 % Patient Days 2,691,710 2,674,331 10,826,574 10,483,236 % Change 0.6 % 3.3 % Equivalent Patient Days 4,850,820 4,786,197 19,314,608 18,639,194 % Change 1.4 % 3.6 % Inpatient Surgery Cases 135,643 132,417 540,704 528,845 % Change 2.4 % 2.2 % Outpatient Surgery Cases 263,832 270,286 1,024,998 1,044,415 % Change -2.4 % -1.9 % Emergency Room Visits 2,498,429 2,452,395 9,789,265 9,342,783 % Change 1.9 % 4.8 % Outpatient Revenues Percentage Patient Revenues 37.9 % 38.4 % 37.8 % 38.3 % Average Length Stay ( days ) 4.814 4.911 4.841 4.920 Occupancy * * 71.7 % 72.5 % 72.7 % 72.3 % Facility : Admissions 552,610 536,350 2,204,148 2,101,839 % Change 3.0 % 4.9 % Equivalent Admissions 980,330 950,949 3,881,505 3,713,950 % Change 3.1 % 4.5 % Revenue per Equivalent Admission $ 18,185 $ 17,674 $ 17,625 $ 17,071 % Change 2.9 % 3.2 % Inpatient Revenue per Admission $ 19,835 $ 19,006 $ 19,085 $ 18,185 % Change 4.4 % 4.9 % Inpatient Surgery Cases 134,482 130,779 534,330 523,074 % Change 2.8 % 2.2 % Outpatient Surgery Cases 257,663 261,155 997,043 1,013,752 % Change -1.3 % -1.6 % Emergency Room Visits 2,466,784 2,410,050 9,642,016 9,192,154 % Change 2.4 % 4.9 % * Excludes freestanding endoscopy centers ( 26 centers December 31 , 2024 24 centers December 31 , 2023 ) .\n",
      "- Supplemental Non-GAAP Disclosures Operating Results Summary ( Dollars millions , except per share amounts ) Years Fourth Quarter Ended December 31 , 2024 2023 2024 2023 Revenues $ 18,285 $ 17,303 $ 70,603 $ 64,968 Net income attributable HCA Healthcare , Inc. $ 1,438 $ 1,607 $ 5,760 $ 5,242 Losses ( gains ) sales facilities ( net tax ) 149 ( 9 ) ( 11 ) 12 Net income attributable HCA Healthcare , Inc. , adjusted ( ) 1,587 1,598 5,749 5,254 Depreciation amortization 856 789 3,312 3,077 Interest expense 528 491 2,061 1,938 Provision income taxes 493 486 1,863 1,608 Net income attributable noncontrolling interests 248 254 897 849 Adjusted EBITDA ( ) 3,712 $ 3,618 $ 13,882 $ 12,726 Adjusted EBITDA margin ( ) 20.3 % 20.9 % 19.7 % 19.6 % Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 5.63 $ 5.93 $ 22.00 $ 18.97 Losses ( gains ) sales facilities 0.59 ( 0.03 ) ( 0.04 ) 0.04 Net income attributable HCA Healthcare , Inc. , adjusted ( ) $ 6.22 $ 5.90 $ 21.96 $ 19.01 Shares used computing diluted earnings per share ( millions ) 255.310 271.186 261.806 276.412 ( ) Net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA considered measures financial performance generally accepted accounting principles ( `` GAAP '' ) .\n",
      "- non-GAAP financial measures adjusted exclude losses ( gains ) sales facilities losses retirement debt .\n",
      "- reasonable expect adjustments , including losses ( gains ) sales facilities losses retirement debt occur future periods , amounts recognized vary significantly period period , directly relate ongoing operations health care facilities complicate period comparisons results operations operations comparisons health care companies .\n",
      "- Supplemental Non-GAAP Disclosures 2025 Operating Results Forecast ( Dollars millions , except per share amounts ) Year Ending December 31 , 2025 Low High Revenues $ 72,800 $ 75,800 Net income attributable HCA Healthcare , Inc. ( ) $ 5,850 $ 6,290 Depreciation amortization 3,495 3,565 Interest expense 2,230 2,320 Provision income taxes 1,800 1,950 Net income attributable noncontrolling interests 925 975 Adjusted EBITDA ( ) ( b ) $ 14,300 $ 15,100 Diluted earnings per share : Net income attributable HCA Healthcare , Inc. $ 24.05 $ 25.85 Shares used computing diluted earnings per share ( millions ) 243.000 243.000 Company 's forecasted guidance based current plans expectations subject number known unknown uncertainties risks .\n",
      "- ( ) Company forecast impact items , limited , losses ( gains ) sales facilities , losses retirement debt , legal claim costs ( benefits ) impairments long-lived assets Company believe forecast items sufficient accuracy .\n",
      "- 12\n",
      "\n",
      "Opportunities:\n",
      "\n",
      "- table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .\n",
      "- 1 facility admissions increased 3.0 percent facility equivalent admissions increased 3.1 percent fourth quarter 2024 , compared prior year period .\n",
      "- table providing supplemental information Adjusted EBITDA reconciling net income attributable HCA Healthcare , Inc. Adjusted EBITDA included release .\n",
      "- Repurchases made accordance applicable securities laws may made management ’ discretion time time open market , privately negotiated transactions , otherwise .\n",
      "- estimates include insurance recoveries Company may receive .\n",
      "- table reconciling forecasted net income attributable HCA Healthcare , Inc. forecasted Adjusted EBITDA included release .\n",
      "- interested investors invited access live audio broadcast call via webcast .\n",
      "- broadcast also available replay basis beginning afternoon .\n",
      "- Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , GAAP net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) health care facilities .\n",
      "- Adjusted EBITDA Adjusted EBITDA margin ( Adjusted EBITDA divided revenues ) utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .\n",
      "- net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA measurements determined accordance GAAP susceptible varying calculations , net income attributable HCA Healthcare , Inc. , adjusted , diluted earnings per share , adjusted , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .\n",
      "- Management investors review overall performance ( including net income attributable HCA Healthcare , Inc. ) operating performance ( Adjusted EBITDA ) healthcare facilities .\n",
      "- Adjusted EBITDA utilized management investors compare current operating results corresponding periods previous year compare operating results companies health care industry .\n",
      "- Adjusted EBITDA measurement determined accordance GAAP susceptible varying calculations , Adjusted EBITDA , presented , may comparable similarly titled measures presented companies .\n",
      "\n",
      "Threats:\n",
      "\n",
      "- December 31 , 2024 , Company $ 7.986 billion availability credit facilities .\n",
      "- repurchase program time limit may suspended periods discontinued time .\n",
      "- Impact Hurricanes fourth quarter 2024 , Company incurred additional expenses experienced loss revenues estimated $ 200 million , $ 0.60 per diluted share , associated Hurricane Helene 's impact North Carolina facilities , well Hurricane Milton , impacted certain facilities Florida .\n",
      "- Forward-Looking Statements press release contains forward-looking statements within meaning federal securities laws , involve risks uncertainties .\n",
      "- Forward-looking statements identified use words like “ may , ” “ believe , ” “ , ” “ expect , ” “ project , ” “ estimate , ” “ anticipate , ” “ plan , ” “ initiative ” “ continue. ” forward-looking statements based current plans expectations subject number known unknown uncertainties risks , many beyond control , could significantly affect current plans expectations future financial position results operations .\n",
      "- factors include , limited , ( 1 ) changes related general economic conditions nationally regionally markets , including inflation economic business conditions ( impact thereof economy , financial markets banking industry ) ; changes revenues due declining patient volumes ; changes payer mix ( including increases uninsured underinsured patients ) ; potential increased expenses related labor , supply chain expenditures ; workforce disruptions ; supply shortages disruptions ( including result geopolitical disruptions ) ; impact potential federal government shutdowns , ( 2 ) impact significant indebtedness ability refinance indebtedness acceptable terms , ( 3 ) impact current future health care public policy developments possible changes federal , state local laws regulations affecting health care industry , including , limited , expiration enhanced premium tax credits individuals eligible purchase insurance coverage federal state-based health insurance marketplaces , ( 4 ) effects related implementation sequestration spending reductions required Budget Control Act 2011 , related legislation extending reductions , potential future deficit reduction legislation may alter spending reductions , include cuts Medicare payments , create additional spending reductions , ( 5 ) increases amount risk collectability uninsured accounts deductibles copayment amounts insured accounts , ( 6 ) ability achieve operating financial targets , attain expected levels patient volumes revenues , control costs providing services , ( 7 ) possible changes Medicare , Medicaid state programs , including Medicaid supplemental payment programs , Medicaid waiver programs state directed payments , may impact reimbursements 4 health care providers insurers size uninsured underinsured population , ( 8 ) personnel-related capacity constraints , increases wages ability attract , utilize retain qualified management personnel , including affiliated physicians , nurses medical technical support personnel , ( 9 ) highly competitive nature health care business , ( 10 ) changes service mix , revenue mix surgical volumes , including potential declines population covered third-party payer agreements , ability enter renew third-party payer provider agreements acceptable terms impact consumer-driven health plans physician utilization trends practices , ( 11 ) efforts health insurers , health care providers , large employer groups others contain health care costs , ( 12 ) outcome continuing efforts monitor , maintain comply appropriate laws , regulations , policies procedures , ( 13 ) availability terms capital fund expansion business improvements existing facilities , ( 14 ) changes accounting practices , ( 15 ) emergence effects related pandemics , epidemics outbreaks infectious diseases public health crises , ( 16 ) future divestitures may result charges possible impairments long-lived assets , ( 17 ) changes business strategy development plans , ( 18 ) delays receiving payments services provided , ( 19 ) outcome pending future tax audits , disputes litigation associated tax positions , ( 20 ) impact known unknown government investigations , litigation claims may made us , ( 21 ) impact actual potential cybersecurity incidents security breaches involving us vendors third parties , ( 22 ) ongoing ability demonstrate meaningful use certified electronic health record technology impact interoperability requirements , ( 23 ) impact natural disasters , hurricanes floods , including Hurricanes Milton Helene , physical risks climate change similar events beyond control assets activities communities serve , ( 24 ) changes U.S. federal , state , foreign tax laws including interpretive guidance may issued taxing authorities standard setting bodies , ( 25 ) results efforts use technology resilience initiatives , including artificial intelligence machine learning , drive efficiencies , better outcomes enhanced patient experience , ( 26 ) impact recent decisions U.S. Supreme Court regarding actions federal agencies , ( 27 ) risk factors described annual report Form 10-K year ended December 31 , 2023 filings Securities Exchange Commission .\n",
      "- Many factors determine future results beyond ability control predict .\n",
      "- light significant uncertainties inherent forward-looking statements contained herein , readers place undue reliance forward-looking statements , reflect management ’ views date hereof .\n",
      "- undertake obligation revise update forward-looking statements , make forward-looking statements , whether result new information , future events otherwise .\n"
     ]
    }
   ],
   "execution_count": 7
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:56:36.290279Z",
     "start_time": "2025-02-17T09:56:30.665455Z"
    }
   },
   "cell_type": "code",
   "source": [
    "\n",
    "\n",
    "def extract_tables_from_pdf(pdf_path):\n",
    "    tables_data = []\n",
    "    with pdfplumber.open(pdf_path) as pdf:\n",
    "        for page in pdf.pages:\n",
    "            tables = page.extract_tables()\n",
    "            for table in tables:\n",
    "                df = pd.DataFrame(table)\n",
    "                df = df.dropna(how='all').reset_index(drop=True) \n",
    "                df.columns = df.iloc[0]\n",
    "                df = df[1:].reset_index(drop=True)\n",
    "                tables_data.append(df)\n",
    "    return tables_data\n",
    "\n",
    "\n",
    "tables_data = extract_tables_from_pdf(pdf_path)\n",
    "print(\"\\nExtracted Tables from PDF:\")\n",
    "for i, table in enumerate(tables_data):\n",
    "    print(f\"\\nTable {i+1}:\")\n",
    "    print(tabulate(table, headers='keys', tablefmt='fancy_grid'))\n",
    "\n",
    "for i, table in enumerate(tables_data):\n",
    "    table.to_csv(f\"table_{i+1}.csv\", index=False)\n"
   ],
   "id": "102d4fe0d80751d4",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Extracted Tables from PDF:\n",
      "\n",
      "Table 1:\n",
      "╒════╤════════════╤════╤════╤════╤════════════════════════════╤════╕\n",
      "│    │ Revenues   │    │    │    │ $72.80 to $75.80 billion   │    │\n",
      "╞════╪════════════╪════╪════╪════╪════════════════════════════╪════╡\n",
      "╘════╧════════════╧════╧════╧════╧════════════════════════════╧════╛\n",
      "\n",
      "Table 2:\n",
      "╒════╤═══════════════════╤════╤════╤════╤════════════════════════════╤════╕\n",
      "│    │ Adjusted EBITDA   │    │    │    │ $14.30 to $15.10 billion   │    │\n",
      "╞════╪═══════════════════╪════╪════╪════╪════════════════════════════╪════╡\n",
      "╘════╧═══════════════════╧════╧════╧════╧════════════════════════════╧════╛\n",
      "\n",
      "Table 3:\n",
      "╒════╤════════════════════════════════════════════════════════════════╤════╤════╤════════╤═════════╤════════╤════════╤════════╤════════╤════╤════╤════╤════════╤═════════╤════════╤════════╤════════╤════════╤════╤════╕\n",
      "│    │                                                                │    │    │ 2024   │ None    │ None   │ None   │ None   │ None   │    │    │    │ 2023   │ None    │ None   │ None   │ None   │ None   │    │    │\n",
      "╞════╪════════════════════════════════════════════════════════════════╪════╪════╪════════╪═════════╪════════╪════════╪════════╪════════╪════╪════╪════╪════════╪═════════╪════════╪════════╪════════╪════════╪════╪════╡\n",
      "│  0 │                                                                │    │    │ Amount │         │        │        │ Ratio  │        │    │    │    │ Amount │         │        │        │ Ratio  │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  1 │ Revenues                                                       │    │    │ $      │ 18,285  │        │        │        │ 100.0  │    │ %  │    │ $      │ 17,303  │        │        │        │ 100.0  │    │ %  │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  2 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  3 │ Salaries and benefits                                          │    │    │        │ 7,917   │        │        │        │ 43.3   │    │    │    │        │ 7,570   │        │        │        │ 43.7   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  4 │ Supplies                                                       │    │    │        │ 2,793   │        │        │        │ 15.3   │    │    │    │        │ 2,584   │        │        │        │ 14.9   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  5 │ Other operating expenses                                       │    │    │        │ 3,873   │        │        │        │ 21.2   │    │    │    │        │ 3,559   │        │        │        │ 20.7   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  6 │ Equity in earnings of affiliates                               │    │    │        │ (10     │ )      │        │        │ (0.1   │ )  │    │    │        │ (28     │ )      │        │        │ (0.2   │ )  │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  7 │ Depreciation and amortization                                  │    │    │        │ 856     │        │        │        │ 4.6    │    │    │    │        │ 789     │        │        │        │ 4.5    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  8 │ Interest expense                                               │    │    │        │ 528     │        │        │        │ 2.9    │    │    │    │        │ 491     │        │        │        │ 2.8    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│  9 │ Losses (gains) on sales of facilities                          │    │    │        │ 195     │        │        │        │ 1.1    │    │    │    │        │ (7      │ )      │        │        │ —      │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 10 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 11 │                                                                │    │    │        │ 16,152  │        │        │        │ 88.3   │    │    │    │        │ 14,958  │        │        │        │ 86.4   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 12 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 13 │ Income before income taxes                                     │    │    │        │ 2,133   │        │        │        │ 11.7   │    │    │    │        │ 2,345   │        │        │        │ 13.6   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 14 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 15 │ Provision for income taxes                                     │    │    │        │ 447     │        │        │        │ 2.5    │    │    │    │        │ 484     │        │        │        │ 2.8    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 16 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 17 │ Net income                                                     │    │    │        │ 1,686   │        │        │        │ 9.2    │    │    │    │        │ 1,861   │        │        │        │ 10.8   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 18 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 19 │ Net income attributable to noncontrolling interests            │    │    │        │ 248     │        │        │        │ 1.3    │    │    │    │        │ 254     │        │        │        │ 1.5    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 20 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 21 │ Net income attributable to HCA Healthcare, Inc.                │    │    │ $      │ 1,438   │        │        │        │ 7.9    │    │    │    │ $      │ 1,607   │        │        │        │ 9.3    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 22 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 23 │ Diluted earnings per share                                     │    │    │ $      │ 5.63    │        │        │        │        │    │    │    │ $      │ 5.93    │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 24 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 25 │ Shares used in computing diluted earnings per share (millions) │    │    │        │ 255.310 │        │        │        │        │    │    │    │        │ 271.186 │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 26 │                                                                │    │    │        │         │        │        │        │        │    │    │    │        │         │        │        │        │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────────┼────────┼────────┼────┼────┤\n",
      "│ 27 │ Comprehensive income attributable to HCA Healthcare, Inc.      │    │    │ $      │ 1,429   │        │        │        │        │    │    │    │ $      │ 1,673   │        │        │        │        │    │    │\n",
      "╘════╧════════════════════════════════════════════════════════════════╧════╧════╧════════╧═════════╧════════╧════════╧════════╧════════╧════╧════╧════╧════════╧═════════╧════════╧════════╧════════╧════════╧════╧════╛\n",
      "\n",
      "Table 4:\n",
      "╒════╤════════════════════════════════════════════════════════════════╤════╤════════╤═════════╤════════╤════╤════╤════╤════════╤═════════╤════════╤════╤════╕\n",
      "│    │                                                                │    │ 2024   │ None    │ None   │    │    │    │ 2023   │ None    │ None   │    │    │\n",
      "╞════╪════════════════════════════════════════════════════════════════╪════╪════════╪═════════╪════════╪════╪════╪════╪════════╪═════════╪════════╪════╪════╡\n",
      "│  0 │                                                                │    │ Amount │         │ Ratio  │    │    │    │ Amount │         │ Ratio  │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  1 │ Revenues                                                       │    │ $      │ 70,603  │ 100.0  │    │ %  │    │ $      │ 64,968  │ 100.0  │    │ %  │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  2 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  3 │ Salaries and benefits                                          │    │        │ 31,170  │ 44.1   │    │    │    │        │ 29,487  │ 45.4   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  4 │ Supplies                                                       │    │        │ 10,755  │ 15.2   │    │    │    │        │ 9,902   │ 15.2   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  5 │ Other operating expenses                                       │    │        │ 14,819  │ 21.0   │    │    │    │        │ 12,875  │ 19.8   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  6 │ Equity in earnings of affiliates                               │    │        │ (23 )   │ —      │    │    │    │        │ (22 )   │ —      │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  7 │ Depreciation and amortization                                  │    │        │ 3,312   │ 4.7    │    │    │    │        │ 3,077   │ 4.7    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  8 │ Interest expense                                               │    │        │ 2,061   │ 2.9    │    │    │    │        │ 1,938   │ 3.0    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│  9 │ Losses (gains) on sales of facilities                          │    │        │ (14 )   │ —      │    │    │    │        │ 5       │ —      │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 10 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 11 │                                                                │    │        │ 62,080  │ 87.9   │    │    │    │        │ 57,262  │ 88.1   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 12 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 13 │ Income before income taxes                                     │    │        │ 8,523   │ 12.1   │    │    │    │        │ 7,706   │ 11.9   │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 14 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 15 │ Provision for income taxes                                     │    │        │ 1,866   │ 2.7    │    │    │    │        │ 1,615   │ 2.5    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 16 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 17 │ Net income                                                     │    │        │ 6,657   │ 9.4    │    │    │    │        │ 6,091   │ 9.4    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 18 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 19 │ Net income attributable to noncontrolling interests            │    │        │ 897     │ 1.2    │    │    │    │        │ 849     │ 1.3    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 20 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 21 │ Net income attributable to HCA Healthcare, Inc.                │    │ $      │ 5,760   │ 8.2    │    │    │    │ $      │ 5,242   │ 8.1    │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 22 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 23 │ Diluted earnings per share                                     │    │ $      │ 22.00   │        │    │    │    │ $      │ 18.97   │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 24 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 25 │ Shares used in computing diluted earnings per share (millions) │    │        │ 261.806 │        │    │    │    │        │ 276.412 │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 26 │                                                                │    │        │         │        │    │    │    │        │         │        │    │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼────────┼─────────┼────────┼────┼────┼────┼────────┼─────────┼────────┼────┼────┤\n",
      "│ 27 │ Comprehensive income attributable to HCA Healthcare, Inc.      │    │ $      │ 5,798   │        │    │    │    │ $      │ 5,307   │        │    │    │\n",
      "╘════╧════════════════════════════════════════════════════════════════╧════╧════════╧═════════╧════════╧════╧════╧════╧════════╧═════════╧════════╧════╧════╛\n",
      "\n",
      "Table 5:\n",
      "╒════╤════════════════════════════════════════════════════════════╤════╤════════════════╤═════════╤════╤════╤═════════════════╤═════════╤════╤════╤════════════════╤═════════╤════╕\n",
      "│    │                                                            │    │ December 31,   │ None    │    │    │ September 30,   │ None    │    │    │ December 31,   │ None    │    │\n",
      "╞════╪════════════════════════════════════════════════════════════╪════╪════════════════╪═════════╪════╪════╪═════════════════╪═════════╪════╪════╪════════════════╪═════════╪════╡\n",
      "│  0 │                                                            │    │ 2024           │         │    │    │ 2024            │         │    │    │ 2023           │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  1 │ ASSETS                                                     │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  2 │ Current assets:                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  3 │ Cash and cash equivalents                                  │    │ $              │ 1,933   │    │    │ $               │ 2,888   │    │    │ $              │ 935     │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  4 │ Accounts receivable                                        │    │                │ 10,751  │    │    │                 │ 9,915   │    │    │                │ 9,958   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  5 │ Inventories                                                │    │                │ 1,738   │    │    │                 │ 1,776   │    │    │                │ 2,021   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  6 │ Other                                                      │    │                │ 1,992   │    │    │                 │ 2,083   │    │    │                │ 2,013   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  7 │                                                            │    │                │ 16,414  │    │    │                 │ 16,662  │    │    │                │ 14,927  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  8 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│  9 │ Property and equipment, at cost                            │    │                │ 62,514  │    │    │                 │ 61,750  │    │    │                │ 58,548  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 10 │ Accumulated depreciation                                   │    │                │ (33,100 │ )  │    │                 │ (32,703 │ )  │    │                │ (30,833 │ )  │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 11 │                                                            │    │                │ 29,414  │    │    │                 │ 29,047  │    │    │                │ 27,715  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 12 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 13 │ Investments of insurance subsidiaries                      │    │                │ 569     │    │    │                 │ 553     │    │    │                │ 477     │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 14 │ Investments in and advances to affiliates                  │    │                │ 662     │    │    │                 │ 705     │    │    │                │ 756     │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 15 │ Goodwill and other intangible assets                       │    │                │ 10,093  │    │    │                 │ 9,982   │    │    │                │ 9,945   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 16 │ Right-of-use operating lease assets                        │    │                │ 2,131   │    │    │                 │ 2,201   │    │    │                │ 2,207   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 17 │ Other                                                      │    │                │ 230     │    │    │                 │ 309     │    │    │                │ 184     │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 18 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 19 │                                                            │    │ $              │ 59,513  │    │    │ $               │ 59,459  │    │    │ $              │ 56,211  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 20 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 21 │ LIABILITIES AND STOCKHOLDERS' EQUITY                       │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 22 │ Current liabilities:                                       │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 23 │ Accounts payable                                           │    │ $              │ 4,276   │    │    │ $               │ 4,235   │    │    │ $              │ 4,233   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 24 │ Accrued salaries                                           │    │                │ 2,304   │    │    │                 │ 2,164   │    │    │                │ 2,127   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 25 │ Other accrued expenses                                     │    │                │ 3,899   │    │    │                 │ 3,819   │    │    │                │ 3,871   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 26 │ Long-term debt due within one year                         │    │                │ 4,698   │    │    │                 │ 4,682   │    │    │                │ 2,424   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 27 │                                                            │    │                │ 15,177  │    │    │                 │ 14,900  │    │    │                │ 12,655  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 28 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 29 │ Long-term debt, less debt issuance costs and discounts     │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 30 │ of $369, $378 and $333                                     │    │                │ 38,333  │    │    │                 │ 38,283  │    │    │                │ 37,169  │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 31 │ Professional liability risks                               │    │                │ 1,544   │    │    │                 │ 1,584   │    │    │                │ 1,557   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 32 │ Right-of-use operating lease obligations                   │    │                │ 1,863   │    │    │                 │ 1,924   │    │    │                │ 1,903   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 33 │ Income taxes and other liabilities                         │    │                │ 2,041   │    │    │                 │ 1,982   │    │    │                │ 1,867   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 34 │                                                            │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 35 │ Stockholders' equity:                                      │    │                │         │    │    │                 │         │    │    │                │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 36 │ Stockholders' deficit attributable to HCA Healthcare, Inc. │    │                │ (2,499  │ )  │    │                 │ (2,182  │ )  │    │                │ (1,774  │ )  │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 37 │ Noncontrolling interests                                   │    │                │ 3,054   │    │    │                 │ 2,968   │    │    │                │ 2,834   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 38 │                                                            │    │                │ 555     │    │    │                 │ 786     │    │    │                │ 1,060   │    │\n",
      "├────┼────────────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────┼────┼─────────────────┼─────────┼────┼────┼────────────────┼─────────┼────┤\n",
      "│ 39 │                                                            │    │ $              │ 59,513  │    │    │ $               │ 59,459  │    │    │ $              │ 56,211  │    │\n",
      "╘════╧════════════════════════════════════════════════════════════╧════╧════════════════╧═════════╧════╧════╧═════════════════╧═════════╧════╧════╧════════════════╧═════════╧════╛\n",
      "\n",
      "Table 6:\n",
      "╒════╤═══════════════════════════════════════════════════════════════════════════════════╤════╤════════╤════════╤════╤════╤════════╤════════╤════╕\n",
      "│    │                                                                                   │    │ 2024   │ None   │    │    │ 2023   │ None   │    │\n",
      "╞════╪═══════════════════════════════════════════════════════════════════════════════════╪════╪════════╪════════╪════╪════╪════════╪════════╪════╡\n",
      "│  0 │ Cash flows from operating activities:                                             │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  1 │ Net income                                                                        │    │ $      │ 6,657  │    │    │ $      │ 6,091  │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  2 │ Adjustments to reconcile net income to net cash provided by operating activities: │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  3 │ Increase (decrease) in cash from operating assets and liabilities:                │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  4 │ Accounts receivable                                                               │    │        │ (799   │ )  │    │        │ (935   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  5 │ Inventories and other assets                                                      │    │        │ 334    │    │    │        │ (126   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  6 │ Accounts payable and accrued expenses                                             │    │        │ 359    │    │    │        │ 604    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  7 │ Depreciation and amortization                                                     │    │        │ 3,312  │    │    │        │ 3,077  │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  8 │ Income taxes                                                                      │    │        │ 22     │    │    │        │ 229    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│  9 │ Losses (gains) on sales of facilities                                             │    │        │ (14    │ )  │    │        │ 5      │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 10 │ Amortization of debt issuance costs and discounts                                 │    │        │ 35     │    │    │        │ 35     │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 11 │ Share-based compensation                                                          │    │        │ 360    │    │    │        │ 262    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 12 │ Other                                                                             │    │        │ 248    │    │    │        │ 189    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 13 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 14 │ Net cash provided by operating activities                                         │    │        │ 10,514 │    │    │        │ 9,431  │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 15 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 16 │ Cash flows from investing activities:                                             │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 17 │ Purchase of property and equipment                                                │    │        │ (4,875 │ )  │    │        │ (4,744 │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 18 │ Acquisition of hospitals and health care entities                                 │    │        │ (266   │ )  │    │        │ (635   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 19 │ Sales of hospitals and health care entities                                       │    │        │ 328    │    │    │        │ 193    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 20 │ Change in investments                                                             │    │        │ (115   │ )  │    │        │ (112   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 21 │ Other                                                                             │    │        │ (5     │ )  │    │        │ (19    │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 22 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 23 │ Net cash used in investing activities                                             │    │        │ (4,933 │ )  │    │        │ (5,317 │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 24 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 25 │ Cash flows from financing activities:                                             │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 26 │ Issuances of long-term debt                                                       │    │        │ 7,495  │    │    │        │ 3,224  │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 27 │ Net change in revolving credit facilities                                         │    │        │ (1,880 │ )  │    │        │ (1,020 │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 28 │ Repayment of long-term debt                                                       │    │        │ (2,410 │ )  │    │        │ (909   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 29 │ Distributions to noncontrolling interests                                         │    │        │ (711   │ )  │    │        │ (640   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 30 │ Payment of debt issuance costs                                                    │    │        │ (67    │ )  │    │        │ (31    │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 31 │ Payment of dividends                                                              │    │        │ (690   │ )  │    │        │ (661   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 32 │ Repurchase of common stock                                                        │    │        │ (6,042 │ )  │    │        │ (3,811 │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 33 │ Other                                                                             │    │        │ (277   │ )  │    │        │ (246   │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 34 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 35 │ Net cash used in financing activities                                             │    │        │ (4,582 │ )  │    │        │ (4,094 │ )  │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 36 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 37 │ Effect of exchange rate changes on cash and cash equivalents                      │    │        │ (1     │ )  │    │        │ 7      │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 38 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 39 │ Change in cash and cash equivalents                                               │    │        │ 998    │    │    │        │ 27     │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 40 │ Cash and cash equivalents at beginning of period                                  │    │        │ 935    │    │    │        │ 908    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 41 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 42 │ Cash and cash equivalents at end of period                                        │    │ $      │ 1,933  │    │    │ $      │ 935    │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 43 │                                                                                   │    │        │        │    │    │        │        │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 44 │ Interest payments                                                                 │    │ $      │ 1,938  │    │    │ $      │ 1,892  │    │\n",
      "├────┼───────────────────────────────────────────────────────────────────────────────────┼────┼────────┼────────┼────┼────┼────────┼────────┼────┤\n",
      "│ 45 │ Income tax payments, net                                                          │    │ $      │ 1,844  │    │    │ $      │ 1,386  │    │\n",
      "╘════╧═══════════════════════════════════════════════════════════════════════════════════╧════╧════════╧════════╧════╧════╧════════╧════════╧════╛\n",
      "\n",
      "Table 7:\n",
      "╒════╤═══════════════════════════════════╤════╤════════════════╤═══════════╤════════╤════════╤════════╤═══════════╤════╤════╤════════════════════╤════════════╤════════╤════════╤════════╤════════════╤════╕\n",
      "│    │                                   │    │                │ None      │ None   │ None   │ None   │ None      │    │    │ For the Years      │ None       │ None   │ None   │ None   │ None       │    │\n",
      "╞════╪═══════════════════════════════════╪════╪════════════════╪═══════════╪════════╪════════╪════════╪═══════════╪════╪════╪════════════════════╪════════════╪════════╪════════╪════════╪════════════╪════╡\n",
      "│  0 │                                   │    │ Fourth Quarter │           │        │        │        │           │    │    │ Ended December 31, │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  1 │                                   │    │ 2024           │           │        │        │ 2023   │           │    │    │ 2024               │            │        │        │ 2023   │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  2 │ Operations:                       │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  3 │ Number of Hospitals               │    │                │ 190       │        │        │        │ 186       │    │    │                    │ 190        │        │        │        │ 186        │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  4 │ Number of Freestanding Outpatient │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  5 │ Surgery Centers*                  │    │                │ 124       │        │        │        │ 124       │    │    │                    │ 124        │        │        │        │ 124        │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  6 │ Licensed Beds at End of Period    │    │                │ 49,985    │        │        │        │ 49,588    │    │    │                    │ 49,985     │        │        │        │ 49,588     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  7 │ Weighted Average Beds in Service  │    │                │ 42,705    │        │        │        │ 42,072    │    │    │                    │ 42,633     │        │        │        │ 41,873     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  8 │                                   │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│  9 │ Reported:                         │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 10 │ Admissions                        │    │                │ 559,170   │        │        │        │ 544,554   │    │    │                    │ 2,236,595  │        │        │        │ 2,130,728  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 11 │ % Change                          │    │                │ 2.7       │ %      │        │        │           │    │    │                    │ 5.0        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 12 │ Equivalent Admissions             │    │                │ 1,007,623 │        │        │        │ 974,561   │    │    │                    │ 3,990,085  │        │        │        │ 3,788,434  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 13 │ % Change                          │    │                │ 3.4       │ %      │        │        │           │    │    │                    │ 5.3        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 14 │ Revenue per Equivalent Admission  │    │ $              │ 18,146    │        │        │ $      │ 17,755    │    │    │ $                  │ 17,695     │        │        │ $      │ 17,149     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 15 │ % Change                          │    │                │ 2.2       │ %      │        │        │           │    │    │                    │ 3.2        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 16 │ Inpatient Revenue per Admission   │    │ $              │ 19,737    │        │        │ $      │ 18,992    │    │    │ $                  │ 19,050     │        │        │ $      │ 18,201     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 17 │ % Change                          │    │                │ 3.9       │ %      │        │        │           │    │    │                    │ 4.7        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 18 │ Patient Days                      │    │                │ 2,691,710 │        │        │        │ 2,674,331 │    │    │                    │ 10,826,574 │        │        │        │ 10,483,236 │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 19 │ % Change                          │    │                │ 0.6       │ %      │        │        │           │    │    │                    │ 3.3        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 20 │ Equivalent Patient Days           │    │                │ 4,850,820 │        │        │        │ 4,786,197 │    │    │                    │ 19,314,608 │        │        │        │ 18,639,194 │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 21 │ % Change                          │    │                │ 1.4       │ %      │        │        │           │    │    │                    │ 3.6        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 22 │ Inpatient Surgery Cases           │    │                │ 135,643   │        │        │        │ 132,417   │    │    │                    │ 540,704    │        │        │        │ 528,845    │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 23 │ % Change                          │    │                │ 2.4       │ %      │        │        │           │    │    │                    │ 2.2        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 24 │ Outpatient Surgery Cases          │    │                │ 263,832   │        │        │        │ 270,286   │    │    │                    │ 1,024,998  │        │        │        │ 1,044,415  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 25 │ % Change                          │    │                │ -2.4      │ %      │        │        │           │    │    │                    │ -1.9       │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 26 │ Emergency Room Visits             │    │                │ 2,498,429 │        │        │        │ 2,452,395 │    │    │                    │ 9,789,265  │        │        │        │ 9,342,783  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 27 │ % Change                          │    │                │ 1.9       │ %      │        │        │           │    │    │                    │ 4.8        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 28 │ Outpatient Revenues as a          │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 29 │ Percentage of Patient Revenues    │    │                │ 37.9      │ %      │        │        │ 38.4      │ %  │    │                    │ 37.8       │ %      │        │        │ 38.3       │ %  │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 30 │ Average Length of Stay (days)     │    │                │ 4.814     │        │        │        │ 4.911     │    │    │                    │ 4.841      │        │        │        │ 4.920      │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 31 │ Occupancy**                       │    │                │ 71.7      │ %      │        │        │ 72.5      │ %  │    │                    │ 72.7       │ %      │        │        │ 72.3       │ %  │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 32 │                                   │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 33 │ Same Facility:                    │    │                │           │        │        │        │           │    │    │                    │            │        │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 34 │ Admissions                        │    │                │ 552,610   │        │        │        │ 536,350   │    │    │                    │ 2,204,148  │        │        │        │ 2,101,839  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 35 │ % Change                          │    │                │ 3.0       │ %      │        │        │           │    │    │                    │ 4.9        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 36 │ Equivalent Admissions             │    │                │ 980,330   │        │        │        │ 950,949   │    │    │                    │ 3,881,505  │        │        │        │ 3,713,950  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 37 │ % Change                          │    │                │ 3.1       │ %      │        │        │           │    │    │                    │ 4.5        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 38 │ Revenue per Equivalent Admission  │    │ $              │ 18,185    │        │        │ $      │ 17,674    │    │    │ $                  │ 17,625     │        │        │ $      │ 17,071     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 39 │ % Change                          │    │                │ 2.9       │ %      │        │        │           │    │    │                    │ 3.2        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 40 │ Inpatient Revenue per Admission   │    │ $              │ 19,835    │        │        │ $      │ 19,006    │    │    │ $                  │ 19,085     │        │        │ $      │ 18,185     │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 41 │ % Change                          │    │                │ 4.4       │ %      │        │        │           │    │    │                    │ 4.9        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 42 │ Inpatient Surgery Cases           │    │                │ 134,482   │        │        │        │ 130,779   │    │    │                    │ 534,330    │        │        │        │ 523,074    │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 43 │ % Change                          │    │                │ 2.8       │ %      │        │        │           │    │    │                    │ 2.2        │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 44 │ Outpatient Surgery Cases          │    │                │ 257,663   │        │        │        │ 261,155   │    │    │                    │ 997,043    │        │        │        │ 1,013,752  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 45 │ % Change                          │    │                │ -1.3      │ %      │        │        │           │    │    │                    │ -1.6       │ %      │        │        │            │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 46 │ Emergency Room Visits             │    │                │ 2,466,784 │        │        │        │ 2,410,050 │    │    │                    │ 9,642,016  │        │        │        │ 9,192,154  │    │\n",
      "├────┼───────────────────────────────────┼────┼────────────────┼───────────┼────────┼────────┼────────┼───────────┼────┼────┼────────────────────┼────────────┼────────┼────────┼────────┼────────────┼────┤\n",
      "│ 47 │ % Change                          │    │                │ 2.4       │ %      │        │        │           │    │    │                    │ 4.9        │ %      │        │        │            │    │\n",
      "╘════╧═══════════════════════════════════╧════╧════════════════╧═══════════╧════════╧════════╧════════╧═══════════╧════╧════╧════════════════════╧════════════╧════════╧════════╧════════╧════════════╧════╛\n",
      "\n",
      "Table 8:\n",
      "╒════╤═════════════════════════════════════════════════════╤════╤════════════════╤═════════╤════════╤════════╤════════╤═════════╤════╤════╤════════════════════╤═════════╤════════╤════════╤════════╤═════════╤════╕\n",
      "│    │                                                     │    │                │ None    │ None   │ None   │ None   │ None    │    │    │ For the Years      │ None    │ None   │ None   │ None   │ None    │    │\n",
      "╞════╪═════════════════════════════════════════════════════╪════╪════════════════╪═════════╪════════╪════════╪════════╪═════════╪════╪════╪════════════════════╪═════════╪════════╪════════╪════════╪═════════╪════╡\n",
      "│  0 │                                                     │    │ Fourth Quarter │         │        │        │        │         │    │    │ Ended December 31, │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  1 │                                                     │    │ 2024           │         │        │        │ 2023   │         │    │    │ 2024               │         │        │        │ 2023   │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  2 │ Revenues                                            │    │ $              │ 18,285  │        │        │ $      │ 17,303  │    │    │ $                  │ 70,603  │        │        │ $      │ 64,968  │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  3 │                                                     │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  4 │ Net income attributable to HCA Healthcare, Inc.     │    │ $              │ 1,438   │        │        │ $      │ 1,607   │    │    │ $                  │ 5,760   │        │        │ $      │ 5,242   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  5 │ Losses (gains) on sales of facilities (net of tax)  │    │                │ 149     │        │        │        │ (9      │ )  │    │                    │ (11     │ )      │        │        │ 12      │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  6 │ Net income attributable to HCA Healthcare, Inc.,    │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  7 │ as adjusted (a)                                     │    │                │ 1,587   │        │        │        │ 1,598   │    │    │                    │ 5,749   │        │        │        │ 5,254   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  8 │ Depreciation and amortization                       │    │                │ 856     │        │        │        │ 789     │    │    │                    │ 3,312   │        │        │        │ 3,077   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  9 │ Interest expense                                    │    │                │ 528     │        │        │        │ 491     │    │    │                    │ 2,061   │        │        │        │ 1,938   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 10 │ Provision for income taxes                          │    │                │ 493     │        │        │        │ 486     │    │    │                    │ 1,863   │        │        │        │ 1,608   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 11 │ Net income attributable to noncontrolling interests │    │                │ 248     │        │        │        │ 254     │    │    │                    │ 897     │        │        │        │ 849     │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 12 │                                                     │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 13 │ Adjusted EBITDA (a)                                 │    │                │ 3,712   │        │        │ $      │ 3,618   │    │    │ $                  │ 13,882  │        │        │ $      │ 12,726  │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 14 │                                                     │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 15 │ Adjusted EBITDA margin (a)                          │    │                │ 20.3    │ %      │        │        │ 20.9    │ %  │    │                    │ 19.7    │ %      │        │        │ 19.6    │ %  │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 16 │                                                     │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 17 │ Diluted earnings per share:                         │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 18 │ Net income attributable to HCA Healthcare, Inc.     │    │ $              │ 5.63    │        │        │ $      │ 5.93    │    │    │ $                  │ 22.00   │        │        │ $      │ 18.97   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 19 │ Losses (gains) on sales of facilities               │    │                │ 0.59    │        │        │        │ (0.03   │ )  │    │                    │ (0.04   │ )      │        │        │ 0.04    │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 20 │ Net income attributable to HCA Healthcare, Inc.,    │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 21 │ as adjusted (a)                                     │    │ $              │ 6.22    │        │        │ $      │ 5.90    │    │    │ $                  │ 21.96   │        │        │ $      │ 19.01   │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 22 │                                                     │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 23 │ Shares used in computing diluted earnings per       │    │                │         │        │        │        │         │    │    │                    │         │        │        │        │         │    │\n",
      "├────┼─────────────────────────────────────────────────────┼────┼────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┼────┼────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 24 │ share (millions)                                    │    │                │ 255.310 │        │        │        │ 271.186 │    │    │                    │ 261.806 │        │        │        │ 276.412 │    │\n",
      "╘════╧═════════════════════════════════════════════════════╧════╧════════════════╧═════════╧════════╧════════╧════════╧═════════╧════╧════╧════════════════════╧═════════╧════════╧════════╧════════╧═════════╧════╛\n",
      "\n",
      "Table 9:\n",
      "╒════╤════════════════════════════════════════════════════════════════╤════╤═══════════════════════╤═════════╤════════╤════════╤════════╤═════════╤════╕\n",
      "│    │                                                                │    │ For the Year Ending   │ None    │ None   │ None   │ None   │ None    │    │\n",
      "╞════╪════════════════════════════════════════════════════════════════╪════╪═══════════════════════╪═════════╪════════╪════════╪════════╪═════════╪════╡\n",
      "│  0 │                                                                │    │ December 31, 2025     │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  1 │                                                                │    │ Low                   │         │        │        │ High   │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  2 │ Revenues                                                       │    │ $                     │ 72,800  │        │        │ $      │ 75,800  │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  3 │                                                                │    │                       │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  4 │ Net income attributable to HCA Healthcare, Inc. (a)            │    │ $                     │ 5,850   │        │        │ $      │ 6,290   │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  5 │ Depreciation and amortization                                  │    │                       │ 3,495   │        │        │        │ 3,565   │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  6 │ Interest expense                                               │    │                       │ 2,230   │        │        │        │ 2,320   │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  7 │ Provision for income taxes                                     │    │                       │ 1,800   │        │        │        │ 1,950   │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  8 │ Net income attributable to noncontrolling interests            │    │                       │ 925     │        │        │        │ 975     │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│  9 │                                                                │    │                       │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 10 │ Adjusted EBITDA (a) (b)                                        │    │ $                     │ 14,300  │        │        │ $      │ 15,100  │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 11 │                                                                │    │                       │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 12 │ Diluted earnings per share:                                    │    │                       │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 13 │ Net income attributable to HCA Healthcare, Inc.                │    │ $                     │ 24.05   │        │        │ $      │ 25.85   │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 14 │                                                                │    │                       │         │        │        │        │         │    │\n",
      "├────┼────────────────────────────────────────────────────────────────┼────┼───────────────────────┼─────────┼────────┼────────┼────────┼─────────┼────┤\n",
      "│ 15 │ Shares used in computing diluted earnings per share (millions) │    │                       │ 243.000 │        │        │        │ 243.000 │    │\n",
      "╘════╧════════════════════════════════════════════════════════════════╧════╧═══════════════════════╧═════════╧════════╧════════╧════════╧═════════╧════╛\n"
     ]
    }
   ],
   "execution_count": 11
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:59:05.952079Z",
     "start_time": "2025-02-17T09:59:05.939295Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "from sklearn.preprocessing import MinMaxScaler\n",
    "from tensorflow import keras\n",
    "from tensorflow.keras.models import Sequential\n",
    "from tensorflow.keras.layers import LSTM, Dense, Dropout\n",
    "from sklearn.metrics import mean_squared_error  # Import MSE directly\n",
    "\n",
    "def create_sequences(data, n_steps):\n",
    "    \"\"\"Creates sequences of data for LSTM input.\"\"\"\n",
    "    X = []\n",
    "    y = []\n",
    "    for i in range(n_steps, len(data)):\n",
    "        X.append(data[i - n_steps:i])\n",
    "        y.append(data[i])\n",
    "    return np.array(X), np.array(y)\n",
    "\n",
    "def train_lstm_model(X_train, y_train, epochs=50, batch_size=32, verbose=1): #verbose set to 1 by default\n",
    "    \"\"\"Trains an LSTM model.\"\"\"\n",
    "    n_features = X_train.shape[2]\n",
    "    timesteps = X_train.shape[1]\n",
    "    model = Sequential()\n",
    "    model.add(LSTM(50, activation='relu', input_shape=(timesteps, n_features), return_sequences=True))  # First LSTM layer (return_sequences=True for stacking)\n",
    "    model.add(Dropout(0.2)) # Add dropout for regularization\n",
    "    model.add(LSTM(50, activation='relu'))  # Second LSTM layer\n",
    "    model.add(Dropout(0.2)) # Add dropout for regularization\n",
    "    model.add(Dense(1)) \n",
    "    model.compile(optimizer='adam', loss='mse')\n",
    "    model.fit(X_train, y_train, epochs=epochs, batch_size=batch_size, verbose=verbose) #verbose is now a parameter\n",
    "    return model\n",
    "\n",
    "def forecast(model, X_test, scaler):\n",
    "    \"\"\"Makes forecast using the trained model and inverse transforms.\"\"\"\n",
    "    predictions = model.predict(X_test)\n",
    "    predictions = predictions.reshape(-1, 1)\n",
    "    predictions = scaler.inverse_transform(np.repeat(predictions, 2, axis=1))\n",
    "    return predictions\n",
    "\n",
    "def evaluate_model(y_true, y_pred):\n",
    "    \"\"\"Evaluates the model and prints metrics.\"\"\"\n",
    "    mse = mean_squared_error(y_true, y_pred) #use sklearn's MSE function\n",
    "    rmse = np.sqrt(mse)\n",
    "    print(f\"MSE: {mse:.4f}\") #format output\n",
    "    print(f\"RMSE: {rmse:.4f}\")\n",
    "    return mse, rmse\n",
    "\n",
    "def main():\n",
    "    # Sample Data (replace with your actual data)\n",
    "    data = {'Date': pd.to_datetime(['2022-01-01', '2022-04-01', '2022-07-01', '2022-10-01', '2023-01-01', '2023-04-01', '2023-07-01']),\n",
    "            'Current Ratio': [1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1],\n",
    "            'Quick Ratio': [0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4]}\n",
    "    df = pd.DataFrame(data)\n",
    "\n",
    "    features = ['Current Ratio', 'Quick Ratio']\n",
    "    data = df[features].values\n",
    "\n",
    "    scaler = MinMaxScaler()\n",
    "    scaled_data = scaler.fit_transform(data)\n",
    "\n",
    "    n_steps = 3\n",
    "    X, y = create_sequences(scaled_data, n_steps)\n",
    "\n",
    "    train_size = int(len(X) * 0.8)\n",
    "    X_train, X_test = X[:train_size], X[train_size:]\n",
    "    y_train, y_test = y[:train_size], y[train_size:]\n",
    "\n",
    "    model = train_lstm_model(X_train, y_train)\n",
    "\n",
    "    predictions = forecast(model, X_test, scaler)\n",
    "    y_test_original_scale = scaler.inverse_transform(y_test) #inverse transform y_test for evaluation\n",
    "\n",
    "    mse, rmse = evaluate_model(y_test_original_scale, predictions) #evaluate on original scale\n",
    "\n",
    "    last_sequence = scaled_data[-n_steps:]\n",
    "    last_sequence = last_sequence.reshape((1, n_steps, len(features)))\n",
    "    future_forecast = forecast(model, last_sequence, scaler)\n",
    "    print(\"Future Forecast:\\n\")\n",
    "    print(\"Current Ratio:\", future_forecast[0][0])\n",
    "    print(\"Quick Ratio:\",future_forecast[0][1])\n",
    "\n",
    "if __name__ == \"_main_\":\n",
    "    main()"
   ],
   "id": "ab06dbaf6d3f3b4d",
   "outputs": [],
   "execution_count": 14
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-02-17T09:59:31.906300Z",
     "start_time": "2025-02-17T09:59:07.063451Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import tkinter as tk\n",
    "from tkinter import ttk  # For modern widgets\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "from sklearn.preprocessing import MinMaxScaler\n",
    "from tensorflow import keras\n",
    "from tensorflow.keras.models import Sequential\n",
    "from tensorflow.keras.layers import LSTM, Dense, Dropout\n",
    "from sklearn.metrics import mean_squared_error\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "def predict_and_display():\n",
    "    try:\n",
    "        data = {'Date': pd.to_datetime(['2022-01-01', '2022-04-01', '2022-07-01', '2022-10-01', '2023-01-01', '2023-04-01', '2023-07-01']),\n",
    "                'Current Ratio': [1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1],\n",
    "                'Quick Ratio': [0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4]}\n",
    "        df = pd.DataFrame(data)\n",
    "\n",
    "        features = ['Current Ratio', 'Quick Ratio']\n",
    "        data = df[features].values\n",
    "\n",
    "        # 2. Scale data\n",
    "        scaler = MinMaxScaler()\n",
    "        scaled_data = scaler.fit_transform(data)\n",
    "\n",
    "        n_steps = 3\n",
    "        X, y = create_sequences(scaled_data, n_steps)\n",
    "\n",
    "        train_size = int(len(X) * 0.8)\n",
    "        X_train, X_test = X[:train_size], X[train_size:]\n",
    "        y_train, y_test = y[:train_size], y[train_size:]\n",
    "\n",
    "        # 3. Train model\n",
    "        model = train_lstm_model(X_train, y_train)\n",
    "\n",
    "        # 4. Make predictions\n",
    "        predictions = forecast(model, X_test, scaler)\n",
    "        y_test_original_scale = scaler.inverse_transform(y_test)\n",
    "\n",
    "        # 5. Evaluate (optional - you can display these too)\n",
    "        mse, rmse = evaluate_model(y_test_original_scale, predictions)\n",
    "\n",
    "        # 6. Future forecast\n",
    "        last_sequence = scaled_data[-n_steps:]\n",
    "        last_sequence = last_sequence.reshape((1, n_steps, len(features)))\n",
    "        future_forecast = forecast(model, last_sequence, scaler)\n",
    "\n",
    "        # 7. Display results in the GUI\n",
    "        for i, feature in enumerate(features):\n",
    "            result_label = result_labels[i]  # Get the label for the feature\n",
    "            forecast_value = future_forecast[0][i]\n",
    "            result_label.config(text=f\"{forecast_value:.4f}\")  # Display with formatting\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"Error: {e}\")\n",
    "        error_label.config(text=f\"An error occurred: {e}\")  # Display error in GUI\n",
    "\n",
    "root = tk.Tk()\n",
    "root.title(\"Financial Forecast\")\n",
    "\n",
    "style = ttk.Style()\n",
    "style.configure('My.TLabel', font=('Helvetica', 12), justify='center')\n",
    "\n",
    "# Create labels for features\n",
    "feature_labels = []\n",
    "for feature in ['Current Ratio', 'Quick Ratio']:\n",
    "    label = ttk.Label(root, text=f\"{feature}:\", style='My.TLabel')  # Apply the style\n",
    "    label.grid(row=len(feature_labels), column=0, padx=5, pady=5, sticky=\"ew\") # Sticky to expand in east/west\n",
    "    feature_labels.append(label)\n",
    "\n",
    "# Create labels to display results\n",
    "result_labels = []\n",
    "for _ in ['Current Ratio', 'Quick Ratio']:\n",
    "    label = ttk.Label(root, text=\"\", style='My.TLabel')  # Apply the style\n",
    "    label.grid(row=len(result_labels), column=1, padx=5, pady=5, sticky=\"ew\") # Sticky to expand in east/west\n",
    "    result_labels.append(label)\n",
    "\n",
    "# Button to trigger prediction\n",
    "predict_button = ttk.Button(root, text=\"Predict\", command=predict_and_display)\n",
    "predict_button.grid(row=len(feature_labels), column=0, columnspan=2, pady=10)\n",
    "\n",
    "error_label = ttk.Label(root, text=\"\", foreground=\"red\", style='My.TLabel')  # Apply style to error label\n",
    "error_label.grid(row=len(feature_labels) + 1, column=0, columnspan=2, pady=(0, 10))\n",
    "\n",
    "# Configure grid column weights to center content\n",
    "root.columnconfigure(0, weight=1)  # Center content in column 0\n",
    "root.columnconfigure(1, weight=1)\n",
    "\n",
    "\n",
    "root.mainloop()"
   ],
   "id": "d1dcb07ed3319f61",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Aaarat\\PycharmProjects\\pythonProject\\.venv\\Lib\\site-packages\\keras\\src\\layers\\rnn\\rnn.py:204: UserWarning: Do not pass an `input_shape`/`input_dim` argument to a layer. When using Sequential models, prefer using an `Input(shape)` object as the first layer in the model instead.\n",
      "  super().__init__(**kwargs)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 1/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m5s\u001B[0m 5s/step - loss: 0.4683\n",
      "Epoch 2/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 67ms/step - loss: 0.4572\n",
      "Epoch 3/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 74ms/step - loss: 0.4571\n",
      "Epoch 4/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 75ms/step - loss: 0.4494\n",
      "Epoch 5/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 58ms/step - loss: 0.4459\n",
      "Epoch 6/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4394\n",
      "Epoch 7/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4329\n",
      "Epoch 8/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.4259\n",
      "Epoch 9/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 52ms/step - loss: 0.4213\n",
      "Epoch 10/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4223\n",
      "Epoch 11/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.4078\n",
      "Epoch 12/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 75ms/step - loss: 0.4049\n",
      "Epoch 13/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 55ms/step - loss: 0.3912\n",
      "Epoch 14/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3914\n",
      "Epoch 15/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3848\n",
      "Epoch 16/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.3764\n",
      "Epoch 17/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 42ms/step - loss: 0.3758\n",
      "Epoch 18/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.3587\n",
      "Epoch 19/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 57ms/step - loss: 0.3590\n",
      "Epoch 20/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.3587\n",
      "Epoch 21/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.3472\n",
      "Epoch 22/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3287\n",
      "Epoch 23/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.3179\n",
      "Epoch 24/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.3152\n",
      "Epoch 25/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.3131\n",
      "Epoch 26/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.3036\n",
      "Epoch 27/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.2844\n",
      "Epoch 28/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 48ms/step - loss: 0.2975\n",
      "Epoch 29/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 58ms/step - loss: 0.2912\n",
      "Epoch 30/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.2615\n",
      "Epoch 31/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.2753\n",
      "Epoch 32/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 56ms/step - loss: 0.2538\n",
      "Epoch 33/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.2351\n",
      "Epoch 34/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.2249\n",
      "Epoch 35/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 57ms/step - loss: 0.2118\n",
      "Epoch 36/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.1689\n",
      "Epoch 37/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 58ms/step - loss: 0.1821\n",
      "Epoch 38/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.1656\n",
      "Epoch 39/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.1570\n",
      "Epoch 40/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 60ms/step - loss: 0.1358\n",
      "Epoch 41/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 45ms/step - loss: 0.1113\n",
      "Epoch 42/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 52ms/step - loss: 0.1432\n",
      "Epoch 43/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.1074\n",
      "Epoch 44/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 43ms/step - loss: 0.0904\n",
      "Epoch 45/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 41ms/step - loss: 0.0801\n",
      "Epoch 46/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.0886\n",
      "Epoch 47/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 52ms/step - loss: 0.0641\n",
      "Epoch 48/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 47ms/step - loss: 0.0436\n",
      "Epoch 49/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 40ms/step - loss: 0.0475\n",
      "Epoch 50/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 32ms/step - loss: 0.0195\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 354ms/step\n",
      "MSE: 0.0044\n",
      "RMSE: 0.0660\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 32ms/step\n",
      "Epoch 1/50\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Aaarat\\PycharmProjects\\pythonProject\\.venv\\Lib\\site-packages\\keras\\src\\layers\\rnn\\rnn.py:204: UserWarning: Do not pass an `input_shape`/`input_dim` argument to a layer. When using Sequential models, prefer using an `Input(shape)` object as the first layer in the model instead.\n",
      "  super().__init__(**kwargs)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m3s\u001B[0m 3s/step - loss: 0.4538\n",
      "Epoch 2/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4486\n",
      "Epoch 3/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 58ms/step - loss: 0.4419\n",
      "Epoch 4/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4298\n",
      "Epoch 5/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 57ms/step - loss: 0.4279\n",
      "Epoch 6/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.4243\n",
      "Epoch 7/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.4099\n",
      "Epoch 8/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 39ms/step - loss: 0.4062\n",
      "Epoch 9/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3936\n",
      "Epoch 10/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.3936\n",
      "Epoch 11/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3867\n",
      "Epoch 12/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3825\n",
      "Epoch 13/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 47ms/step - loss: 0.3809\n",
      "Epoch 14/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.3706\n",
      "Epoch 15/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3435\n",
      "Epoch 16/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 52ms/step - loss: 0.3580\n",
      "Epoch 17/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 42ms/step - loss: 0.3232\n",
      "Epoch 18/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 39ms/step - loss: 0.3378\n",
      "Epoch 19/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 44ms/step - loss: 0.3159\n",
      "Epoch 20/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.3043\n",
      "Epoch 21/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.3080\n",
      "Epoch 22/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.2934\n",
      "Epoch 23/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 56ms/step - loss: 0.2587\n",
      "Epoch 24/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.2665\n",
      "Epoch 25/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 58ms/step - loss: 0.2501\n",
      "Epoch 26/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.2528\n",
      "Epoch 27/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.2197\n",
      "Epoch 28/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 66ms/step - loss: 0.2191\n",
      "Epoch 29/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.2157\n",
      "Epoch 30/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.2217\n",
      "Epoch 31/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 60ms/step - loss: 0.1901\n",
      "Epoch 32/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 44ms/step - loss: 0.1730\n",
      "Epoch 33/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.1860\n",
      "Epoch 34/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 57ms/step - loss: 0.1384\n",
      "Epoch 35/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 62ms/step - loss: 0.1282\n",
      "Epoch 36/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 99ms/step - loss: 0.1078\n",
      "Epoch 37/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 52ms/step - loss: 0.1161\n",
      "Epoch 38/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 56ms/step - loss: 0.0891\n",
      "Epoch 39/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 51ms/step - loss: 0.0895\n",
      "Epoch 40/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 44ms/step - loss: 0.0951\n",
      "Epoch 41/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 43ms/step - loss: 0.0434\n",
      "Epoch 42/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 48ms/step - loss: 0.0314\n",
      "Epoch 43/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 55ms/step - loss: 0.0221\n",
      "Epoch 44/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 43ms/step - loss: 0.0388\n",
      "Epoch 45/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.0145\n",
      "Epoch 46/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 45ms/step - loss: 0.0153\n",
      "Epoch 47/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.0290\n",
      "Epoch 48/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 49ms/step - loss: 0.0114\n",
      "Epoch 49/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 39ms/step - loss: 0.0153\n",
      "Epoch 50/50\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 50ms/step - loss: 0.0110\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 299ms/step\n",
      "MSE: 0.0001\n",
      "RMSE: 0.0102\n",
      "\u001B[1m1/1\u001B[0m \u001B[32m━━━━━━━━━━━━━━━━━━━━\u001B[0m\u001B[37m\u001B[0m \u001B[1m0s\u001B[0m 26ms/step\n"
     ]
    }
   ],
   "execution_count": 15
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
